LL-100：修订间差异
删除的内容 添加的内容
| 第1行： | 第1行： | ||
'''{{PAGENAME}}'''是100种[[人类]][[淋巴瘤]]（'''L'''ymphoma）与[[白血病]]（'''L'''eukemia）[[细胞系]]的列表<ref name=:0>{{cite journal |last1=Quentmeier |first1=H |last2=Pommerenke |first2=C |last3=Dirks |first3=WG |last4=Eberth |first4=S |last5=Koeppel |first5=M |last6=MacLeod |first6=RAF |last7=Nagel |first7=S |last8=Steube |first8=K |last9=Uphoff |first9=CC |last10=Drexler |first10=HG |title=The LL-100 panel: 100 cell lines for blood cancer studies. |journal=Scientific Reports |date=3 June 2019 |volume=9 |issue=1 |pages=8218 |doi=10.1038/s41598-019-44491-x |pmid=31160637|pmc=6547646 |bibcode=2019NatSR...9.8218Q }}</ref>，用于[[药物筛选]]等许多生物[[医学研究]]<ref name=:1>{{cite journal |last1=Drexler |first1=HG |last2=Quentmeier |first2=H |title=The LL-100 Cell Lines Panel: Tool for Molecular Leukemia-Lymphoma Research. |journal=International Journal of Molecular Sciences |date=13 August 2020 |volume=21 |issue=16 |page=5800 |doi=10.3390/ijms21165800 |pmid=32823535|pmc=7461097 |doi-access=free }}</ref>。 |
'''{{PAGENAME}}'''是100种[[人类]][[淋巴瘤]]（'''L'''ymphoma）与[[白血病]]（'''L'''eukemia）[[细胞系]]的列表<ref name=:0>{{cite journal |last1=Quentmeier |first1=H |last2=Pommerenke |first2=C |last3=Dirks |first3=WG |last4=Eberth |first4=S |last5=Koeppel |first5=M |last6=MacLeod |first6=RAF |last7=Nagel |first7=S |last8=Steube |first8=K |last9=Uphoff |first9=CC |last10=Drexler |first10=HG |title=The LL-100 panel: 100 cell lines for blood cancer studies. |journal=Scientific Reports |date=3 June 2019 |volume=9 |issue=1 |pages=8218 |doi=10.1038/s41598-019-44491-x |pmid=31160637|pmc=6547646 |bibcode=2019NatSR...9.8218Q }}</ref>，用于[[药物筛选]]等许多生物[[医学研究]]<ref name=:1>{{cite journal |last1=Drexler |first1=HG |last2=Quentmeier |first2=H |title=The LL-100 Cell Lines Panel: Tool for Molecular Leukemia-Lymphoma Research. |journal=International Journal of Molecular Sciences |date=13 August 2020 |volume=21 |issue=16 |page=5800 |doi=10.3390/ijms21165800 |pmid=32823535|pmc=7461097 |doi-access=free }}</ref>。 |
||
==细胞系== |
==细胞系== |
||
===Pre-B-ALL=== |
|||
{| class="wikitable sortable" |
|||
! Cell line !! Sex !! Age !! Ref !! [[Cellosaurus]] |
|||
|- |
|||
| [[697 (cell line)|697]] || Male || 12Y || <ref>{{cite journal |last1=Findley HW |first1=Jr |last2=Cooper |first2=MD |last3=Kim |first3=TH |last4=Alvarado |first4=C |last5=Ragab |first5=AH |title=Two new acute lymphoblastic leukemia cell lines with early B-cell phenotypes. |journal=Blood |date=December 1982 |volume=60 |issue=6 |pages=1305–9 |doi=10.1182/blood.V60.6.1305.1305 |pmid=6982733|doi-access=free }}</ref> || [https://www.cellosaurus.org/CVCL_0079 CVCL_0079] |
|||
|- |
|||
| [[KOPN-8]] || Female || 3M || <ref>{{cite journal |last1=Uphoff |first1=CC |last2=MacLeod |first2=RA |last3=Denkmann |first3=SA |last4=Golub |first4=TR |last5=Borkhardt |first5=A |last6=Janssen |first6=JW |last7=Drexler |first7=HG |title=Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in human early B-lineage leukemia cell lines. |journal=Leukemia |date=March 1997 |volume=11 |issue=3 |pages=441–7 |doi=10.1038/sj.leu.2400571 |pmid=9067587|s2cid=37823510 }}</ref> || [https://www.cellosaurus.org/CVCL_1866 CVCL_1866] |
|||
|- |
|||
| [[NALM-6]] || Male || 19Y || <ref>{{cite journal |last1=Hurwitz |first1=R |last2=Hozier |first2=J |last3=LeBien |first3=T |last4=Minowada |first4=J |last5=Gajl-Peczalska |first5=K |last6=Kubonishi |first6=I |last7=Kersey |first7=J |title=Characterization of a leukemic cell line of the pre-B phenotype. |journal=International Journal of Cancer |date=February 1979 |volume=23 |issue=2 |pages=174–80 |doi=10.1002/ijc.2910230206 |pmid=83966|s2cid=29853203 }}</ref> || [https://www.cellosaurus.org/CVCL_0092 CVCL_0092] |
|||
|- |
|||
| [[REH (cell line)|REH]] || Female || 15Y || <ref>{{cite journal |last1=Rosenfeld |first1=C |last2=Goutner |first2=A |last3=Venuat |first3=AM |last4=Choquet |first4=C |last5=Pico |first5=JL |last6=Dore |first6=JF |last7=Liabeuf |first7=A |last8=Durandy |first8=A |last9=Desgrange |first9=C |last10=De The |first10=G |title=An effect human leukaemic cell line: Reh. |journal=European Journal of Cancer |date=April 1977 |volume=13 |issue=4–5 |pages=377–9 |doi=10.1016/0014-2964(77)90085-8 |pmid=194778}}</ref> || [https://www.cellosaurus.org/CVCL_1650 CVCL_1650] |
|||
|- |
|||
| [[SEM (cell line)|SEM]] || Female || 5Y || <ref>{{cite journal |last1=Greil |first1=J |last2=Gramatzki |first2=M |last3=Burger |first3=R |last4=Marschalek |first4=R |last5=Peltner |first5=M |last6=Trautmann |first6=U |last7=Hansen-Hagge |first7=TE |last8=Bartram |first8=CR |last9=Fey |first9=GH |last10=Stehr |first10=K |title=The acute lymphoblastic leukaemia cell line SEM with t(4;11) chromosomal rearrangement is biphenotypic and responsive to interleukin-7. |journal=British Journal of Haematology |date=February 1994 |volume=86 |issue=2 |pages=275–83 |doi=10.1111/j.1365-2141.1994.tb04726.x |pmid=8199015|s2cid=44321104 }}</ref> || [https://www.cellosaurus.org/CVCL_0095 CVCL_0095] |
|||
|} |
|||
===B-NHL：[[伯基特淋巴瘤]]/B-ALL=== |
===B-NHL：[[伯基特淋巴瘤]]/B-ALL=== |
||
{| class="wikitable sortable" |
{| class="wikitable sortable" |
||
| 第15行： | 第30行： | ||
| [[VAL (cell line)|VAL]] || Female || 50Y || <ref>{{cite journal |last1=Kerckaert |first1=JP |last2=Deweindt |first2=C |last3=Tilly |first3=H |last4=Quief |first4=S |last5=Lecocq |first5=G |last6=Bastard |first6=C |title=LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. |journal=Nature Genetics |date=September 1993 |volume=5 |issue=1 |pages=66–70 |doi=10.1038/ng0993-66 |pmid=8220427|s2cid=12575122 }}</ref> || [https://www.cellosaurus.org/CVCL_1819 CVCL_1819] |
| [[VAL (cell line)|VAL]] || Female || 50Y || <ref>{{cite journal |last1=Kerckaert |first1=JP |last2=Deweindt |first2=C |last3=Tilly |first3=H |last4=Quief |first4=S |last5=Lecocq |first5=G |last6=Bastard |first6=C |title=LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. |journal=Nature Genetics |date=September 1993 |volume=5 |issue=1 |pages=66–70 |doi=10.1038/ng0993-66 |pmid=8220427|s2cid=12575122 }}</ref> || [https://www.cellosaurus.org/CVCL_1819 CVCL_1819] |
||
|- |
|- |
||
|} |
|||
===B-NHL: [[Chronic lymphocytic leukemia|CLL]]/PLL=== |
|||
{| class="wikitable sortable" |
|||
! Cell line !! Sex !! Age !! Ref !! [[Cellosaurus]] |
|||
|- |
|||
| [[HG-3]] || Male || 70Y || <ref>{{cite journal |last1=Rosén |first1=A |last2=Bergh |first2=AC |last3=Gogok |first3=P |last4=Evaldsson |first4=C |last5=Myhrinder |first5=AL |last6=Hellqvist |first6=E |last7=Rasul |first7=A |last8=Björkholm |first8=M |last9=Jansson |first9=M |last10=Mansouri |first10=L |last11=Liu |first11=A |last12=Teh |first12=BT |last13=Rosenquist |first13=R |last14=Klein |first14=E |title=Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infection. |journal=Oncoimmunology |date=1 January 2012 |volume=1 |issue=1 |pages=18–27 |doi=10.4161/onci.1.1.18400 |pmid=22720208|pmc=3376971 }}</ref> || [https://www.cellosaurus.org/CVCL_Y547 CVCL_Y547] |
|||
|- |
|||
| [[JVM-3]] || Male || 73Y || <ref name=JVM>{{cite journal |last1=Melo |first1=JV |last2=Brito-Babapulle |first2=V |last3=Foroni |first3=L |last4=Robinson |first4=DS |last5=Luzzatto |first5=L |last6=Catovsky |first6=D |title=Two new cell lines from B-prolymphocytic leukaemia: characterization by morphology, immunological markers, karyotype and Ig gene rearrangement. |journal=International Journal of Cancer |date=15 October 1986 |volume=38 |issue=4 |pages=531–8 |doi=10.1002/ijc.2910380413 |pmid=3093393|s2cid=10813284 }}</ref> || [https://www.cellosaurus.org/CVCL_1320 CVCL_1320] |
|||
|- |
|||
| [[JVM-13]] || Male || 60-69Y || <ref>{{cite journal |last1=Melo |first1=JV |last2=Foroni |first2=L |last3=Brito-Babapulle |first3=V |last4=Luzzatto |first4=L |last5=Catovsky |first5=D |title=The establishment of cell lines from chronic B cell leukaemias: evidence of leukaemic origin by karyotypic abnormalities and Ig gene rearrangement. |journal=Clinical and Experimental Immunology |date=July 1988 |volume=73 |issue=1 |pages=23–8 |pmid=3262465|pmc=1541467 }}</ref> || [https://www.cellosaurus.org/CVCL_1318 CVCL_1318] |
|||
|- |
|||
| [[MEC-1]] || Male || 61Y || <ref>{{cite journal |last1=Stacchini |first1=A |last2=Aragno |first2=M |last3=Vallario |first3=A |last4=Alfarano |first4=A |last5=Circosta |first5=P |last6=Gottardi |first6=D |last7=Faldella |first7=A |last8=Rege-Cambrin |first8=G |last9=Thunberg |first9=U |last10=Nilsson |first10=K |last11=Caligaris-Cappio |first11=F |title=MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation. |journal=Leukemia Research |date=February 1999 |volume=23 |issue=2 |pages=127–36 |doi=10.1016/s0145-2126(98)00154-4 |pmid=10071128}}</ref> || [https://www.cellosaurus.org/CVCL_1870 CVCL_1870] |
|||
|- |
|||
| [[PGA-1]] || Male || unspecified || <ref>{{cite journal |last1=Lewin |first1=N |last2=Aman |first2=P |last3=Mellstedt |first3=H |last4=Zech |first4=L |last5=Klein |first5=G |title=Direct outgrowth of in vivo Epstein-Barr virus (EBV)-infected chronic lymphocytic leukemia (CLL) cells into permanent lines. |journal=International Journal of Cancer |date=15 June 1988 |volume=41 |issue=6 |pages=892–5 |doi=10.1002/ijc.2910410621 |pmid=2836321|s2cid=38575113 }}</ref> || [https://www.cellosaurus.org/CVCL_Y545 CVCL_Y545] |
|||
|- |
|||
|} |
|||
===B-NHL: DLBCL ABC=== |
|||
{| class="wikitable sortable" |
|||
! Cell line !! Sex !! Age !! Ref !! [[Cellosaurus]] |
|||
|- |
|||
| [[NU-DHL-1]] || Male || 73Y || <ref>{{cite journal |last1=Epstein |first1=AL |last2=Variakojis |first2=D |last3=Berger |first3=C |last4=Hecht |first4=BK |title=Use of novel chemical supplements in the establishment of three human malignant lymphoma cell lines (NU-DHL-1, NU-DUL-1, and NU-AMB-1) with chromosome 14 translocations. |journal=International Journal of Cancer |date=15 May 1985 |volume=35 |issue=5 |pages=619–27 |doi=10.1002/ijc.2910350509 |pmid=2581902|s2cid=38530935 }}</ref> || [https://www.cellosaurus.org/CVCL_1876 CVCL_1876] |
|||
|- |
|||
| [[OCI-Ly3]] || Male || 52Y || <ref name="The presence of clonogenic cells in">{{cite journal |last1=Tweeddale |first1=ME |last2=Lim |first2=B |last3=Jamal |first3=N |last4=Robinson |first4=J |last5=Zalcberg |first5=J |last6=Lockwood |first6=G |last7=Minden |first7=MD |last8=Messner |first8=HA |title=The presence of clonogenic cells in high-grade malignant lymphoma: a prognostic factor. |journal=Blood |date=May 1987 |volume=69 |issue=5 |pages=1307–14 |doi=10.1182/blood.V69.5.1307.1307 |pmid=3567358|doi-access=free }}</ref> || [https://www.cellosaurus.org/CVCL_8800 CVCL_8800] |
|||
|- |
|||
| [[RI-1 (cell line)|Ri-1]] || Female || 57Y || <ref>{{cite journal |last1=Th'ng |first1=KH |last2=Garewal |first2=G |last3=Kearney |first3=L |last4=Rassool |first4=F |last5=Melo |first5=JV |last6=White |first6=H |last7=Catovsky |first7=D |last8=Foroni |first8=L |last9=Luzzatto |first9=L |last10=Goldman |first10=JM |title=Establishment and characterization of three new malignant lymphoid cell lines. |journal=International Journal of Cancer |date=15 January 1987 |volume=39 |issue=1 |pages=89–93 |doi=10.1002/ijc.2910390116 |pmid=3098690|s2cid=23849509 }}</ref> || [https://www.cellosaurus.org/CVCL_1885 CVCL_1885] |
|||
|- |
|||
| [[U-2932]] || Female || 29Y || <ref>{{cite journal |last1=Amini |first1=RM |last2=Berglund |first2=M |last3=Rosenquist |first3=R |last4=Von Heideman |first4=A |last5=Lagercrantz |first5=S |last6=Thunberg |first6=U |last7=Bergh |first7=J |last8=Sundström |first8=C |last9=Glimelius |first9=B |last10=Enblad |first10=G |title=A novel B-cell line (U-2932) established from a patient with diffuse large B-cell lymphoma following Hodgkin lymphoma. |journal=Leukemia & Lymphoma |date=November 2002 |volume=43 |issue=11 |pages=2179–89 |doi=10.1080/1042819021000032917 |pmid=12533045|s2cid=23476994 }}</ref> || [https://www.cellosaurus.org/CVCL_1896 CVCL_1896] |
|||
|- |
|||
| [[U-2946]] || Male || 52Y || <ref>{{cite journal |last1=Fridberg |first1=M |last2=Servin |first2=A |last3=Anagnostaki |first3=L |last4=Linderoth |first4=J |last5=Berglund |first5=M |last6=Söderberg |first6=O |last7=Enblad |first7=G |last8=Rosén |first8=A |last9=Mustelin |first9=T |last10=Jerkeman |first10=M |last11=Persson |first11=JL |last12=Wingren |first12=AG |title=Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN. |journal=Leukemia & Lymphoma |date=November 2007 |volume=48 |issue=11 |pages=2221–32 |doi=10.1080/10428190701636443 |pmid=17926183|s2cid=17523509 |url=http://urn.kb.se/resolve?urn=urn:nbn:se:mau:diva-4801 }}</ref> || [https://www.cellosaurus.orgCVCL_X503 CVCL_X503] |
|||
|} |
|||
===B-NHL: DLBCL GC=== |
|||
{| class="wikitable sortable" |
|||
! Cell line !! Sex !! Age !! Ref !! [[Cellosaurus]] |
|||
|- |
|||
| [[DoHH2]] || Male || 60Y || <ref>{{cite journal |last1=Kluin-Nelemans |first1=HC |last2=Limpens |first2=J |last3=Meerabux |first3=J |last4=Beverstock |first4=GC |last5=Jansen |first5=JH |last6=de Jong |first6=D |last7=Kluin |first7=PM |title=A new non-Hodgkin's B-cell line (DoHH2) with a chromosomal translocation t(14;18)(q32;q21). |journal=Leukemia |date=March 1991 |volume=5 |issue=3 |pages=221–4 |pmid=1849602}}</ref> || [https://www.cellosaurus.org/CVCL_1179 CVCL_1179] |
|||
|- |
|||
| [[OCI-Ly7]] || Male || 48Y || <ref name="The presence of clonogenic cells in"/> || [https://www.cellosaurus.orgCVCL_1881 CVCL_1881] |
|||
|- |
|||
| [[OCI-Ly19]] || Female || 27Y || <ref>{{cite journal |last1=Chang |first1=H |last2=Blondal |first2=JA |last3=Benchimol |first3=S |last4=Minden |first4=MD |last5=Messner |first5=HA |title=p53 mutations, c-myc and bcl-2 rearrangements in human non-Hodgkin's lymphoma cell lines. |journal=Leukemia & Lymphoma |date=September 1995 |volume=19 |issue=1–2 |pages=165–71 |doi=10.3109/10428199509059672 |pmid=8574164}}</ref> || [https://www.cellosaurus.org/CVCL_1878 CVCL_1878] |
|||
|- |
|||
| [[SU-DHL-4]] || Male || 38Y || <ref name=SU-DHL>{{cite journal |last1=Epstein |first1=AL |last2=Herman |first2=MM |last3=Kim |first3=H |last4=Dorfman |first4=RF |last5=Kaplan |first5=HS |title=Biology of the human malignant lymphomas. III. Intracranial heterotransplantation in the nude, athymic mouse. |journal=Cancer |date=May 1976 |volume=37 |issue=5 |pages=2158–76 |doi=10.1002/1097-0142(197605)37:5<2158::aid-cncr2820370503>3.0.co;2-f |pmid=177185|s2cid=6013844 }}</ref> || [https://www.cellosaurus.org/CVCL_0539 CVCL_0539] |
|||
|- |
|||
| [[SU-DHL-6]] || Male || 43Y || <ref name=SU-DHL/> || [https://www.cellosaurus.org/CVCL_2206 CVCL_2206] |
|||
|- |
|||
| [[WSU-DLCL2]] || Male || 41Y || <ref>{{cite journal |last1=Al-Katib |first1=AM |last2=Smith |first2=MR |last3=Kamanda |first3=WS |last4=Pettit |first4=GR |last5=Hamdan |first5=M |last6=Mohamed |first6=AN |last7=Chelladurai |first7=B |last8=Mohammad |first8=RM |title=Bryostatin 1 down-regulates mdr1 and potentiates vincristine cytotoxicity in diffuse large cell lymphoma xenografts. |journal=Clinical Cancer Research |date=May 1998 |volume=4 |issue=5 |pages=1305–14 |pmid=9607591}}</ref> || [https://www.cellosaurus.org/CVCL_1902 CVCL_1902] |
|||
|} |
|||
===B-NHL: [[Hairy cell leukemia|HCL]]=== |
|||
{| class="wikitable sortable" |
|||
! Cell line !! Sex !! Age !! Ref !! [[Cellosaurus]] |
|||
|- |
|||
| [[BONNA-12]] || Male || 46Y || <ref>{{cite journal |last1=Wientjens |first1=GJ |last2=Jansen |first2=JH |last3=Wessels |first3=HW |last4=Kibbelaar |first4=RE |last5=Beverstock |first5=GC |last6=Brederoo |first6=P |last7=Kluin-Nelemans |first7=HC |title=Characterization of a New Human B Cell Line (Bonna-12) with Trisomy 9 and Trisomy 12 Chromosomal Abnormality. |journal=Leukemia & Lymphoma |date=1991 |volume=5 |issue=5–6 |pages=415–22 |doi=10.3109/10428199109067637 |pmid=27463354}}</ref> || [https://www.cellosaurus.org/CVCL_1090 CVCL_1090] |
|||
|- |
|||
| [[Hair-M]] || Male || 86Y || <ref>{{cite journal |last1=Matsuo |first1=Y |last2=Sagawa |first2=K |last3=Yokoyama |first3=M |last4=Koga |first4=T |last5=Yamaguchi |first5=T |last6=Morita |first6=M |last7=Minowada |first7=J |title=[Establishment and characterization of hairy cell leukemia cell line (Hair-M)]. |journal=Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society |date=November 1983 |volume=46 |issue=6 |pages=1222–32 |pmid=6608852}}</ref> || [https://www.cellosaurus.org/CVCL_B401 CVCL_B401] |
|||
|- |
|||
| [[HC-1 (cell line)|HC-1]] || Male || 56Y || <ref>{{cite journal |last1=Schiller |first1=JH |last2=Bittner |first2=G |last3=Meisner |first3=LF |last4=Oberley |first4=TD |last5=Norback |first5=D |last6=Schwabe |first6=M |last7=Faltynek |first7=CR |last8=Raab-Traub |first8=N |title=Establishment and characterization of an Epstein-Barr virus spontaneously transformed lymphocytic cell line derived from a hairy cell leukemia patient. |journal=Leukemia |date=May 1991 |volume=5 |issue=5 |pages=399–407 |pmid=1851909}}</ref> || [https://www.cellosaurus.org/CVCL_1243 CVCL_1243] |
|||
|} |
|||
===B-NHL: [[Mantle cell lymphoma|MCL]]=== |
|||
{| class="wikitable sortable" |
|||
! Cell line !! Sex !! Age !! Ref !! [[Cellosaurus]] |
|||
|- |
|||
| [[Granta-519]] || Female || 58Y || <ref>{{cite journal |last1=Lukas |first1=J |last2=Jadayel |first2=D |last3=Bartkova |first3=J |last4=Nacheva |first4=E |last5=Dyer |first5=MJ |last6=Strauss |first6=M |last7=Bartek |first7=J |title=BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation. |journal=Oncogene |date=August 1994 |volume=9 |issue=8 |pages=2159–67 |pmid=8036001}}</ref> || [https://www.cellosaurus.org/CVCL_1818 CVCL_1818] |
|||
|- |
|||
| [[JeKo-1]] || Female || 78Y || <ref>{{cite journal |last1=Jeon |first1=HJ |last2=Kim |first2=CW |last3=Yoshino |first3=T |last4=Akagi |first4=T |title=Establishment and characterization of a mantle cell lymphoma cell line. |journal=British Journal of Haematology |date=September 1998 |volume=102 |issue=5 |pages=1323–6 |doi=10.1046/j.1365-2141.1998.00911.x |pmid=9753063|s2cid=29818033 |doi-access=free }}</ref> || [https://www.cellosaurus.org/CVCL_1865 CVCL_1865] |
|||
|- |
|||
| [[JVM-2]] || Female || 63Y || <ref name=JVM/> || [https://www.cellosaurus.org/CVCL_1319 CVCL_1319] |
|||
|- |
|||
| [[Mino (cell line)|Mino]] || Male || 68Y || <ref>{{cite journal |last1=Lai |first1=R |last2=McDonnell |first2=TJ |last3=O'Connor |first3=SL |last4=Medeiros |first4=LJ |last5=Oudat |first5=R |last6=Keating |first6=M |last7=Morgan |first7=MB |last8=Curiel |first8=TJ |last9=Ford |first9=RJ |title=Establishment and characterization of a new mantle cell lymphoma cell line, Mino. |journal=Leukemia Research |date=September 2002 |volume=26 |issue=9 |pages=849–55 |doi=10.1016/s0145-2126(02)00013-9 |pmid=12127561}}</ref> || [https://www.cellosaurus.org/CVCL_1872 CVCL_1872] |
|||
|- |
|||
| [[REC-1]] || Male || 61Y || <ref>{{cite journal |last1=Szepetowski |first1=P |last2=Simon |first2=MP |last3=Grosgeorge |first3=J |last4=Huebner |first4=K |last5=Bastard |first5=C |last6=Evans |first6=GA |last7=Tsujimoto |first7=Y |last8=Birnbaum |first8=D |last9=Theillet |first9=C |last10=Gaudray |first10=P |title=Localization of 11q13 loci with respect to regional chromosomal breakpoints. |journal=Genomics |date=April 1992 |volume=12 |issue=4 |pages=738–44 |doi=10.1016/0888-7543(92)90303-a |pmid=1572647}}</ref> || [https://www.cellosaurus.org/CVCL_1884 CVCL_1884] |
|||
|- |
|||
|} |
|||
===B-NHL: PEL=== |
|||
{| class="wikitable sortable" |
|||
! Cell line !! Sex !! Age !! Ref !! [[Cellosaurus]] |
|||
|- |
|||
| [[BC-3 (cell line)|BC-3]] || Male || 85Y || <ref>{{cite journal |last1=Arvanitakis |first1=L |last2=Mesri |first2=EA |last3=Nador |first3=RG |last4=Said |first4=JW |last5=Asch |first5=AS |last6=Knowles |first6=DM |last7=Cesarman |first7=E |title=Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. |journal=Blood |date=1 October 1996 |volume=88 |issue=7 |pages=2648–54 |doi=10.1182/blood.V88.7.2648.bloodjournal8872648 |pmid=8839859|doi-access=free }}</ref> || [https://www.cellosaurus.org/CVCL_1080 CVCL_1080] |
|||
|- |
|||
| [[BCBL-1]] || Male || 40Y || <ref>{{cite journal |last1=Renne |first1=R |last2=Zhong |first2=W |last3=Herndier |first3=B |last4=McGrath |first4=M |last5=Abbey |first5=N |last6=Kedes |first6=D |last7=Ganem |first7=D |title=Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. |journal=Nature Medicine |date=March 1996 |volume=2 |issue=3 |pages=342–6 |doi=10.1038/nm0396-342 |pmid=8612236|s2cid=20384290 }}</ref> || [https://www.cellosaurus.org/CVCL_0165 CVCL_0165] |
|||
|- |
|||
| [[CRO-AP2]] || Male || 49Y || <ref>{{cite journal |last1=Carbone |first1=A |last2=Cilia |first2=AM |last3=Gloghini |first3=A |last4=Canzonieri |first4=V |last5=Pastore |first5=C |last6=Todesco |first6=M |last7=Cozzi |first7=M |last8=Perin |first8=T |last9=Volpe |first9=R |last10=Pinto |first10=A |last11=Gaidano |first11=G |title=Establishment of HHV-8-positive and HHV-8-negative lymphoma cell lines from primary lymphomatous effusions. |journal=International Journal of Cancer |date=14 November 1997 |volume=73 |issue=4 |pages=562–9 |doi=10.1002/(sici)1097-0215(19971114)73:4<562::aid-ijc18>3.0.co;2-b |pmid=9389573|s2cid=32367275 }}</ref> || [https://www.cellosaurus.org/CVCL_1147 CVCL_1147] |
|||
|- |
|||
| [[CRO-AP5]] || Male || 35Y || <ref>{{cite journal |last1=Carbone |first1=A |last2=Cilia |first2=AM |last3=Gloghini |first3=A |last4=Capello |first4=D |last5=Todesco |first5=M |last6=Quattrone |first6=S |last7=Volpe |first7=R |last8=Gaidano |first8=G |title=Establishment and characterization of EBV-positive and EBV-negative primary effusion lymphoma cell lines harbouring human herpesvirus type-8. |journal=British Journal of Haematology |date=September 1998 |volume=102 |issue=4 |pages=1081–9 |doi=10.1046/j.1365-2141.1998.00877.x |pmid=9734661|s2cid=23440348 |doi-access=free }}</ref> || [https://www.cellosaurus.org/CVCL_1148 CVCL_1148] |
|||
|} |
|||
===B-NHL: PMBL=== |
|||
{| class="wikitable sortable" |
|||
! Cell line !! Sex !! Age !! Ref !! [[Cellosaurus]] |
|||
|- |
|||
| [[U-2940]] || Female || 18Y || <ref>{{cite journal |last1=Sambade |first1=C |last2=Berglund |first2=M |last3=Lagercrantz |first3=S |last4=Sällström |first4=J |last5=Reis |first5=RM |last6=Enblad |first6=G |last7=Glimelius |first7=B |last8=Sundström |first8=C |title=U-2940, a human B-cell line derived from a diffuse large cell lymphoma sequential to Hodgkin lymphoma. |journal=International Journal of Cancer |date=1 February 2006 |volume=118 |issue=3 |pages=555–63 |doi=10.1002/ijc.21417 |pmid=16106419|s2cid=12837372 |doi-access=free }}</ref> || [https://www.cellosaurus.org/CVCL_1897 CVCL_1897] |
|||
|} |
|||
===[[Multiple Myeloma]]/PCL=== |
|||
{| class="wikitable sortable" |
|||
! Cell line !! Sex !! Age !! Ref !! [[Cellosaurus]] |
|||
|- |
|||
| [[KMS-12-BM]] || Female || 64Y || <ref>{{cite journal |last1=Ohtsuki |first1=T |last2=Yawata |first2=Y |last3=Wada |first3=H |last4=Sugihara |first4=T |last5=Mori |first5=M |last6=Namba |first6=M |title=Two human myeloma cell lines, amylase-producing KMS-12-PE and amylase-non-producing KMS-12-BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;q32). |journal=British Journal of Haematology |date=October 1989 |volume=73 |issue=2 |pages=199–204 |doi=10.1111/j.1365-2141.1989.tb00252.x |pmid=2479409|s2cid=29676750 }}</ref> || [https://www.cellosaurus.org/CVCL_1334 CVCL_1334] |
|||
|- |
|||
| [[L-363]] || Female || 36Y || <ref>{{cite journal |last1=Diehl |first1=V |last2=Schaadt |first2=M |last3=Kirchner |first3=H |last4=Hellriegel |first4=KP |last5=Gudat |first5=F |last6=Fonatsch |first6=C |last7=Laskewitz |first7=E |last8=Guggenheim |first8=R |title=Long-term cultivation of plasma cell leukemia cells and autologous lymphoblasts (LCL) in vitro: a comparative study. |journal=Blut |date=20 June 1978 |volume=36 |issue=6 |pages=331–8 |doi=10.1007/BF01000590 |pmid=207377|s2cid=22828123 }}</ref> || [https://www.cellosaurus.org/CVCL_1357 CVCL_1357] |
|||
|- |
|||
| [[LP-1]] || Female || 56Y || <ref>{{cite journal |last1=Pegoraro |first1=L |last2=Malavasi |first2=F |last3=Bellone |first3=G |last4=Massaia |first4=M |last5=Boccadoro |first5=M |last6=Saglio |first6=G |last7=Guerrasio |first7=A |last8=Benetton |first8=G |last9=Lombardi |first9=L |last10=Coda |first10=R |title=The human myeloma cell line LP-1: a versatile model in which to study early plasma-cell differentiation and c-myc activation. |journal=Blood |date=March 1989 |volume=73 |issue=4 |pages=1020–7 |doi=10.1182/blood.V73.4.1020.1020 |pmid=2784066|doi-access=free }}</ref> || [https://www.cellosaurus.org/CVCL_0012 CVCL_0012] |
|||
|- |
|||
| [[OPM-2]] || Female || 56Y || <ref>{{cite journal |last1=Katagiri |first1=S |last2=Yonezawa |first2=T |last3=Kuyama |first3=J |last4=Kanayama |first4=Y |last5=Nishida |first5=K |last6=Abe |first6=T |last7=Tamaki |first7=T |last8=Ohnishi |first8=M |last9=Tarui |first9=S |title=Two distinct human myeloma cell lines originating from one patient with myeloma. |journal=International Journal of Cancer |date=15 August 1985 |volume=36 |issue=2 |pages=241–6 |doi=10.1002/ijc.2910360217 |pmid=3926660|s2cid=20506312 }}</ref> || [https://www.cellosaurus.org/CVCL_1625 CVCL_1625] |
|||
|- |
|||
| [[RPMI-8226]] || Male || 61Y || <ref>{{cite journal |last1=Matsuoka |first1=Y |last2=Moore |first2=GE |last3=Yagi |first3=Y |last4=Pressman |first4=D |title=Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. |journal=Proceedings of the Society for Experimental Biology and Medicine |date=August 1967 |volume=125 |issue=4 |pages=1246–50 |doi=10.3181/00379727-125-32327 |pmid=6042436|s2cid=9643262 }}</ref> || [https://www.cellosaurus.org/CVCL_0014 CVCL_0014] |
|||
|- |
|||
| [[U266B1|U-266]] || Male || 53Y || <ref>{{cite journal |last1=Nilsson |first1=K |last2=Bennich |first2=H |last3=Johansson |first3=SG |last4=Pontén |first4=J |title=Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient. |journal=Clinical and Experimental Immunology |date=October 1970 |volume=7 |issue=4 |pages=477–89 |pmid=4097745|pmc=1712861 }}</ref> || [https://www.cellosaurus.org/CVCL_0566 CVCL_0566] |
|||
|} |
|||
===[[Hodgkin Lymphoma]]=== |
|||
{| class="wikitable sortable" |
|||
! Cell line !! Sex !! Age !! Ref !! [[Cellosaurus]] |
|||
|- |
|||
| [[HDLM-2]] || Male || 74Y || <ref name=Hodgkin>{{cite journal |last1=Drexler |first1=HG |last2=Gaedicke |first2=G |last3=Lok |first3=MS |last4=Diehl |first4=V |last5=Minowada |first5=J |title=Hodgkin's disease derived cell lines HDLM-2 and L-428: comparison of morphology, immunological and isoenzyme profiles. |journal=Leukemia Research |date=1986 |volume=10 |issue=5 |pages=487–500 |doi=10.1016/0145-2126(86)90084-6 |pmid=3713248}}</ref> || [https://www.cellosaurus.org/CVCL_0009 CVCL_0009] |
|||
|- |
|||
| [[KM-H2]] || Male || 37Y || <ref>{{cite journal |last1=Kamesaki |first1=H |last2=Fukuhara |first2=S |last3=Tatsumi |first3=E |last4=Uchino |first4=H |last5=Yamabe |first5=H |last6=Miwa |first6=H |last7=Shirakawa |first7=S |last8=Hatanaka |first8=M |last9=Honjo |first9=T |title=Cytochemical, immunologic, chromosomal, and molecular genetic analysis of a novel cell line derived from Hodgkin's disease. |journal=Blood |date=July 1986 |volume=68 |issue=1 |pages=285–92 |doi=10.1182/blood.V68.1.285.285 |pmid=3013343|doi-access=free }}</ref> || [https://www.cellosaurus.org/CVCL_1330 CVCL_1330] |
|||
|- |
|||
| [[L-428]] || Female || 37Y || <ref name=Hodgkin/> || [https://www.cellosaurus.org/CVCL_1361 CVCL_1361] |
|||
|- |
|||
| [[L-1236]] || Male || 34Y || <ref>{{cite journal |last1=Wolf |first1=J |last2=Kapp |first2=U |last3=Bohlen |first3=H |last4=Kornacker |first4=M |last5=Schoch |first5=C |last6=Stahl |first6=B |last7=Mücke |first7=S |last8=von Kalle |first8=C |last9=Fonatsch |first9=C |last10=Schaefer |first10=HE |last11=Hansmann |first11=ML |last12=Diehl |first12=V |title=Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells. |journal=Blood |date=15 April 1996 |volume=87 |issue=8 |pages=3418–28 |doi=10.1182/blood.V87.8.3418.bloodjournal8783418 |pmid=8605360|doi-access=free }}</ref> || [https://www.cellosaurus.org/CVCL_2096 CVCL_2096] |
|||
|- |
|||
| [[SUP-HD1]] || Male || 37Y || <ref>{{cite journal |last1=Naumovski |first1=L |last2=Utz |first2=PJ |last3=Bergstrom |first3=SK |last4=Morgan |first4=R |last5=Molina |first5=A |last6=Toole |first6=JJ |last7=Glader |first7=BE |last8=McFall |first8=P |last9=Weiss |first9=LM |last10=Warnke |first10=R |title=SUP-HD1: a new Hodgkin's disease-derived cell line with lymphoid features produces interferon-gamma. |journal=Blood |date=December 1989 |volume=74 |issue=8 |pages=2733–42 |doi=10.1182/blood.V74.8.2733.2733 |pmid=2554995|doi-access=free }}</ref> || [https://www.cellosaurus.org/CVCL_2208 CVCL_2208] |
|||
|} |
|||
===T-ALL/T-LL=== |
|||
{| class="wikitable sortable" |
|||
! Cell line !! Sex !! Age !! Ref !! [[Cellosaurus]] |
|||
|- |
|||
| {{ill|CCRF-CEM|zh|CCRF-CEM}} || Female || 3Y11M || <ref>{{cite journal |last1=FOLEY |first1=GE |last2=LAZARUS |first2=H |last3=FARBER |first3=S |last4=UZMAN |first4=BG |last5=BOONE |first5=BA |last6=MCCARTHY |first6=RE |title=Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia |journal=Cancer |date=April 1965 |volume=18 |issue=4 |pages=522–9 |doi=10.1002/1097-0142(196504)18:4<522::aid-cncr2820180418>3.0.co;2-j |pmid=14278051|s2cid=32647486 |doi-access=free }}</ref> || [https://www.cellosaurus.org/CVCL_0207 CVCL_0207] |
|||
|- |
|||
| {{ill|DND-41|zh|DND-41}} || Male || 13Y || <ref>{{cite journal |last1=Heyman |first1=M |last2=Grandér |first2=D |last3=Bröndum-Nielsen |first3=K |last4=Cederblad |first4=B |last5=Liu |first5=Y |last6=Xu |first6=B |last7=Einhorn |first7=S |title=Interferon system defects in malignant T-cells. |journal=Leukemia |date=March 1994 |volume=8 |issue=3 |pages=425–34 |pmid=8127147}}</ref> || [https://www.cellosaurus.org/CVCL_2022 CVCL_2022] |
|||
|- |
|||
| [[HPB-ALL]] || Male || 14Y || <ref name=E-rosette>{{cite journal |last1=Morikawa |first1=S |last2=Tatsumi |first2=E |last3=Baba |first3=M |last4=Harada |first4=T |last5=Yasuhira |first5=K |title=Two E-rosette-forming lymphoid cell lines. |journal=International Journal of Cancer |date=15 February 1978 |volume=21 |issue=2 |pages=166–70 |doi=10.1002/ijc.2910210207 |pmid=203546|s2cid=9032666 }}</ref> || [https://www.cellosaurus.org/CVCL_1820 CVCL_1820] |
|||
|- |
|||
| [[Jurkat cells|Jurkat]] || Male || 14Y || <ref>{{cite journal |last1=Abraham |first1=RT |last2=Weiss |first2=A |title=Jurkat T cells and development of the T-cell receptor signalling paradigm. |journal=Nature Reviews. Immunology |date=April 2004 |volume=4 |issue=4 |pages=301–8 |doi=10.1038/nri1330 |pmid=15057788|s2cid=13253575 }}</ref> || [https://www.cellosaurus.org/CVCL_0065 CVCL_0065] |
|||
|- |
|||
| [[MOLT-4]] || Male || 19Y || <ref>{{cite journal |last1=Minowada |first1=J |last2=Onuma |first2=T |last3=Moore |first3=GE |title=Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. |journal=Journal of the National Cancer Institute |date=September 1972 |volume=49 |issue=3 |pages=891–5 |pmid=4567231}}</ref> || [https://www.cellosaurus.org/CVCL_0013 CVCL_0013] |
|||
|- |
|||
| [[RPMI-8402]] || Female || 16Y || <ref>{{cite journal |last1=Huang |first1=CC |last2=Hou |first2=Y |last3=Woods |first3=LK |last4=Moore |first4=GE |last5=Minowada |first5=J |title=Cytogenetic study of human lymphoid T-cell lines derived from lymphocytic leukemia. |journal=Journal of the National Cancer Institute |date=September 1974 |volume=53 |issue=3 |pages=655–60 |doi=10.1093/jnci/53.3.655 |pmid=4547172}}</ref> || [https://www.cellosaurus.org/CVCL_1667 CVCL_1667] |
|||
|} |
|||
===Mature T-Malignancy=== |
|||
{| class="wikitable sortable" |
|||
! Cell line !! Sex !! Age !! Ref !! [[Cellosaurus]] |
|||
|- |
|||
| [[DERL-7]] || Male || 30Y || <ref>{{cite journal |last1=Di Noto |first1=R |last2=Pane |first2=F |last3=Camera |first3=A |last4=Luciano |first4=L |last5=Barone |first5=M |last6=Lo Pardo |first6=C |last7=Boccuni |first7=P |last8=Intrieri |first8=M |last9=Izzo |first9=B |last10=Villa |first10=MR |last11=Macrí |first11=M |last12=Rotoli |first12=B |last13=Sacchetti |first13=L |last14=Salvatore |first14=F |last15=Del Vecchio |first15=L |title=Characterization of two novel cell lines, DERL-2 (CD56+/CD3+/Tcry5+) and DERL-7 (CD56+/CD3-/TCRgammadelta-), derived from a single patient with CD56+ non-Hodgkin's lymphoma. |journal=Leukemia |date=October 2001 |volume=15 |issue=10 |pages=1641–9 |doi=10.1038/sj.leu.2402239 |pmid=11587224|s2cid=25177712 }}</ref> || [https://www.cellosaurus.org/CVCL_2017 CVCL_2017] |
|||
|- |
|||
| [[HH (cell line)|HH]] || Male || 61Y || <ref>{{cite journal |last1=Starkebaum |first1=G |last2=Loughran TP |first2=Jr |last3=Waters |first3=CA |last4=Ruscetti |first4=FW |title=Establishment of an IL-2 independent, human T-cell line possessing only the p70 IL-2 receptor. |journal=International Journal of Cancer |date=9 September 1991 |volume=49 |issue=2 |pages=246–53 |doi=10.1002/ijc.2910490218 |pmid=1879969|s2cid=8605186 }}</ref> || [https://www.cellosaurus.org/CVCL_1280 CVCL_1280] |
|||
|- |
|||
| [[MOTN-1]] || Female || 65Y || <ref>{{cite journal |last1=Matsuo |first1=Y |last2=Drexler |first2=HG |last3=Takeuchi |first3=M |last4=Tanaka |first4=M |last5=Orita |first5=K |title=Establishment of the T-cell large granular lymphocyte leukemia cell line MOTN-1 carrying natural killer-cell antigens. |journal=Leukemia Research |date=September 2002 |volume=26 |issue=9 |pages=873–9 |doi=10.1016/s0145-2126(02)00023-1 |pmid=12127564}}</ref> || [https://www.cellosaurus.org/CVCL_2127 CVCL_2127] |
|||
|} |
|||
===NK Malignancy=== |
|||
{| class="wikitable sortable" |
|||
! Cell line !! Sex !! Age !! Ref !! [[Cellosaurus]] |
|||
|- |
|||
| [[KHYG-1]] || Female || 45Y || <ref>{{cite journal |last1=Yagita |first1=M |last2=Huang |first2=CL |last3=Umehara |first3=H |last4=Matsuo |first4=Y |last5=Tabata |first5=R |last6=Miyake |first6=M |last7=Konaka |first7=Y |last8=Takatsuki |first8=K |title=A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation. |journal=Leukemia |date=May 2000 |volume=14 |issue=5 |pages=922–30 |doi=10.1038/sj.leu.2401769 |pmid=10803526|s2cid=22938275 }}</ref> || [https://www.cellosaurus.org/CVCL_2976 CVCL_2976] |
|||
|- |
|||
| [[NK-92]] || Male || 50Y || <ref>Gong, J., Maki, G., and Klingemann, H-G. (1994). “Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells”. Leukemia; 8: 652-58.</ref> || [https://www.cellosaurus.org/CVCL_2142 CVCL_2142] |
|||
|- |
|||
| [[YT (cell line)|YT]] || Male || 15Y || <ref>{{cite journal |last1=Yodoi |first1=J |last2=Teshigawara |first2=K |last3=Nikaido |first3=T |last4=Fukui |first4=K |last5=Noma |first5=T |last6=Honjo |first6=T |last7=Takigawa |first7=M |last8=Sasaki |first8=M |last9=Minato |first9=N |last10=Tsudo |first10=M |title=TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells). |journal=Journal of Immunology |date=March 1985 |volume=134 |issue=3 |pages=1623–30 |doi=10.4049/jimmunol.134.3.1623 |pmid=2578514|s2cid=13147698 |doi-access=free }}</ref> || [https://www.cellosaurus.org/CVCL_1797 CVCL_1797] |
|||
|} |
|||
===[[Anaplastic large-cell lymphoma|ALCL]]=== |
|||
{| class="wikitable sortable" |
|||
! Cell line !! Sex !! Age !! Ref !! [[Cellosaurus]] |
|||
|- |
|||
| [[DEL (cell line)|DEL]] || Male || 12Y || <ref>{{cite journal |last1=Barbey |first1=S |last2=Gogusev |first2=J |last3=Mouly |first3=H |last4=Le Pelletier |first4=O |last5=Smith |first5=W |last6=Richard |first6=S |last7=Soulie |first7=J |last8=Nezelof |first8=C |title=DEL cell line: a "malignant histiocytosis" CD30+ t(5;6)(q35;p21) cell line. |journal=International Journal of Cancer |date=15 March 1990 |volume=45 |issue=3 |pages=546–53 |doi=10.1002/ijc.2910450329 |pmid=2307542|s2cid=1472373 }}</ref> || [https://www.cellosaurus.org/CVCL_1170 CVCL_1170] |
|||
|- |
|||
| [[SR-786 (cell line)|SR-786]] || Male || 11Y || <ref>{{cite journal |last1=Su |first1=IJ |last2=Balk |first2=SP |last3=Kadin |first3=ME |title=Molecular basis for the aberrant expression of T cell antigens in postthymic T cell malignancies. |journal=The American Journal of Pathology |date=August 1988 |volume=132 |issue=2 |pages=192–8 |pmid=2456698|pmc=1880737 }}</ref> || [https://www.cellosaurus.org/CVCL_1711 CVCL_1711] |
|||
|- |
|||
| [[SU-DHL-1]] || Male || 10Y || <ref>{{cite journal |last1=Epstein |first1=AL |last2=Kaplan |first2=HS |title=Biology of the human malignant lymphomas. I. Establishment in continuous cell culture and heterotransplantation of diffuse histiocytic lymphomas. |journal=Cancer |date=December 1974 |volume=34 |issue=6 |pages=1851–72 |doi=10.1002/1097-0142(197412)34:6<1851::aid-cncr2820340602>3.0.co;2-4 |pmid=4140017|s2cid=27701046 |doi-access=free }}</ref> || [https://www.cellosaurus.org/CVCL_0538 CVCL_0538] |
|||
|- |
|||
| [[SUP-M2]] || Female || 5Y || <ref>{{cite journal |last1=Morgan |first1=R |last2=Smith |first2=SD |last3=Hecht |first3=BK |last4=Christy |first4=V |last5=Mellentin |first5=JD |last6=Warnke |first6=R |last7=Cleary |first7=ML |title=Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5)(p23;q35) common to malignancies with features of so-called malignant histiocytosis. |journal=Blood |date=June 1989 |volume=73 |issue=8 |pages=2155–64 |doi=10.1182/blood.V73.8.2155.2155 |pmid=2525056|doi-access=free }}</ref> || [https://www.cellosaurus.org/CVCL_2209 CVCL_2209] |
|||
|} |
|||
===AML myelocytic=== |
|||
{| class="wikitable sortable" |
|||
! Cell line !! Sex !! Age !! Ref !! [[Cellosaurus]] |
|||
|- |
|||
| {{ill|EoL-1|zh|EoL-1}} || Male || 33Y || <ref>{{cite journal |last1=Mayumi |first1=M |title=EoL-1, a human eosinophilic cell line. |journal=Leukemia & Lymphoma |date=June 1992 |volume=7 |issue=3 |pages=243–50 |doi=10.3109/10428199209053629 |pmid=1477652 |url=https://pubmed.ncbi.nlm.nih.gov/1477652-eol-1-a-human-eosinophilic-cell-line/ |accessdate=2019-12-23 |archive-url=https://web.archive.org/web/20191223092723/https://pubmed.ncbi.nlm.nih.gov/1477652-eol-1-a-human-eosinophilic-cell-line/ |archive-date=2019-12-23 |url-status=dead}}</ref> || [https://www.cellosaurus.org/CVCL_0258 CVCL_0258] |
|||
|- |
|||
| [[HL60|HL-60]] || Female || 36Y || <ref name="pmid288488">{{cite journal |last1=Gallagher |first1=R |last2=Collins |first2=S |last3=Trujillo |first3=J |last4=McCredie |first4=K |last5=Ahearn |first5=M |last6=Tsai |first6=S |last7=Metzgar |first7=R |last8=Aulakh |first8=G |last9=Ting |first9=R |last10=Ruscetti |first10=F |last11=Gallo |first11=R |title=Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. |journal=Blood |date=September 1979 |volume=54 |issue=3 |pages=713–33 |doi=10.1182/blood.V54.3.713.713 |pmid=288488|doi-access=free }}</ref> || [https://www.cellosaurus.org/CVCL_0002 CVCL_0002] |
|||
|- |
|||
| [[Kasumi-1]] || Male || 7Y || <ref>{{cite journal |last1=Asou |first1=H |last2=Tashiro |first2=S |last3=Hamamoto |first3=K |last4=Otsuji |first4=A |last5=Kita |first5=K |last6=Kamada |first6=N |title=Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation. |journal=Blood |date=1 May 1991 |volume=77 |issue=9 |pages=2031–6 |doi=10.1182/blood.V77.9.2031.2031 |pmid=2018839|doi-access=free }}</ref> || [https://www.cellosaurus.org/CVCL_0589 CVCL_0589] |
|||
|- |
|||
| {{ill|KG-1|zh|KG-1}} || Male || 59Y || <ref>{{cite journal |last1=Mrózek |first1=K |last2=Tanner |first2=SM |last3=Heinonen |first3=K |last4=Bloomfield |first4=CD |title=Molecular cytogenetic characterization of the KG-1 and KG-1a acute myeloid leukemia cell lines by use of spectral karyotyping and fluorescence in situ hybridization. |journal=Genes, Chromosomes & Cancer |date=November 2003 |volume=38 |issue=3 |pages=249–52 |doi=10.1002/gcc.10274 |pmid=14506699|s2cid=6018408 |doi-access=free }}</ref> || [https://www.cellosaurus.org/CVCL_0374 CVCL_0374] |
|||
|- |
|||
| [[NB4]] || Female || 23Y || <ref>{{cite journal |last1=Lanotte |first1=M |last2=Martin-Thouvenin |first2=V |last3=Najman |first3=S |last4=Balerini |first4=P |last5=Valensi |first5=F |last6=Berger |first6=R |title=NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). |journal=Blood |date=1 March 1991 |volume=77 |issue=5 |pages=1080–6 |doi=10.1182/blood.V77.5.1080.1080 |pmid=1995093|doi-access=free }}</ref> || [https://www.cellosaurus.org/CVCL_0005 CVCL_0005] |
|||
|- |
|||
| [[OCI-AML3]] || Male || 57Y || <ref>{{cite journal |last1=Wang |first1=C |last2=Curtis |first2=JE |last3=Minden |first3=MD |last4=McCulloch |first4=EA |title=Expression of a retinoic acid receptor gene in myeloid leukemia cells. |journal=Leukemia |date=April 1989 |volume=3 |issue=4 |pages=264–9 |pmid=2538684}}</ref> || [https://www.cellosaurus.org/CVCL_1844 CVCL_1844] |
|||
|- |
|||
| [[SKNO-1]] || Male || 22Y || <ref>{{cite journal |last1=Matozaki |first1=S |last2=Nakagawa |first2=T |last3=Kawaguchi |first3=R |last4=Aozaki |first4=R |last5=Tsutsumi |first5=M |last6=Murayama |first6=T |last7=Koizumi |first7=T |last8=Nishimura |first8=R |last9=Isobe |first9=T |last10=Chihara |first10=K |title=Establishment of a myeloid leukaemic cell line (SKNO-1) from a patient with t(8;21) who acquired monosomy 17 during disease progression. |journal=British Journal of Haematology |date=April 1995 |volume=89 |issue=4 |pages=805–11 |doi=10.1111/j.1365-2141.1995.tb08418.x |pmid=7772516|s2cid=40610063 }}</ref> || [https://web.expasy.org/cellosaurus/CVCL_2196 CVCL_2196] |
|||
|} |
|||
===AML monocytic=== |
|||
{| class="wikitable sortable" |
|||
! Cell line !! Sex !! Age !! Ref !! [[Cellosaurus]] |
|||
|- |
|||
| [[ME-1 (cell line)|ME-1]] || Male || 40Y || <ref>{{cite journal |last1=Yanagisawa |first1=K |last2=Horiuchi |first2=T |last3=Fujita |first3=S |title=Establishment and characterization of a new human leukemia cell line derived from M4E0. |journal=Blood |date=15 July 1991 |volume=78 |issue=2 |pages=451–7 |doi=10.1182/blood.V78.2.451.451 |pmid=2070080|doi-access=free }}</ref> || [https://www.cellosaurus.org/CVCL_2110 CVCL_2110] |
|||
|- |
|||
| [[MOLM-13]] || Male || 20Y || <ref>{{cite journal |last1=Matsuo |first1=Y |last2=MacLeod |first2=RA |last3=Uphoff |first3=CC |last4=Drexler |first4=HG |last5=Nishizaki |first5=C |last6=Katayama |first6=Y |last7=Kimura |first7=G |last8=Fujii |first8=N |last9=Omoto |first9=E |last10=Harada |first10=M |last11=Orita |first11=K |title=Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins(11;9)(q23;p22p23). |journal=Leukemia |date=September 1997 |volume=11 |issue=9 |pages=1469–77 |doi=10.1038/sj.leu.2400768 |pmid=9305600|s2cid=205678428 }}</ref> || [https://www.cellosaurus.org/CVCL_2119 CVCL_2119] |
|||
|- |
|||
| [[Mono-Mac-6]] || Male || 64Y || <ref>{{cite journal |last1=Ziegler-Heitbrock |first1=HW |last2=Thiel |first2=E |last3=Fütterer |first3=A |last4=Herzog |first4=V |last5=Wirtz |first5=A |last6=Riethmüller |first6=G |title=Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. |journal=International Journal of Cancer |date=15 March 1988 |volume=41 |issue=3 |pages=456–61 |doi=10.1002/ijc.2910410324 |pmid=3162233|s2cid=23268646 }}</ref> || [https://www.cellosaurus.org/CVCL_1426 CVCL_1426] |
|||
|- |
|||
| [[MUTZ-3]] || Male || 29Y || <ref>{{cite journal |last1=Hu |first1=ZB |last2=Ma |first2=W |last3=Zaborski |first3=M |last4=MacLeod |first4=R |last5=Quentmeier |first5=H |last6=Drexler |first6=HG |title=Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3. |journal=Leukemia |date=June 1996 |volume=10 |issue=6 |pages=1025–40 |pmid=8667638}}</ref> || [https://www.cellosaurus.org/CVCL_1433 CVCL_1433] |
|||
|- |
|||
| [[THP-1 cell line|THP-1]] || Male || 1Y || <ref name=pmid6970727>{{cite journal | vauthors = Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K | title = Establishment and characterization of a human acute monocytic leukemia cell line (THP-1) | journal = International Journal of Cancer | volume = 26 | issue = 2 | pages = 171–6 | date = August 1980 | pmid = 6970727 | doi = 10.1002/ijc.2910260208 | s2cid = 43603660 }}</ref> || [https://www.cellosaurus.org/CVCL_0006 CVCL_0006] |
|||
|- |
|||
| [[U937 (cell line)|U-937]] || Male || 37Y || <ref name="Sundstrom">{{cite journal | author = Sundström C | title = Establishment and characterization of a human histiocytic lymphoma cell line (U-937) | journal = Int. J. Cancer | volume = 17 | issue = 5 | pages = 565–77 | date = May 1976 | pmid = 178611 | doi=10.1002/ijc.2910170504| s2cid = 19334036 }}</ref> || [https://www.cellosaurus.org/CVCL_0007 CVCL_0007] |
|||
|} |
|||
===AML erythroid=== |
|||
{| class="wikitable sortable" |
|||
! Cell line !! Sex !! Age !! Ref !! [[Cellosaurus]] |
|||
|- |
|||
| [[F-36P]] || Male || 68Y || <ref>{{cite journal |last1=Chiba |first1=S |last2=Takaku |first2=F |last3=Tange |first3=T |last4=Shibuya |first4=K |last5=Misawa |first5=C |last6=Sasaki |first6=K |last7=Miyagawa |first7=K |last8=Yazaki |first8=Y |last9=Hirai |first9=H |title=Establishment and erythroid differentiation of a cytokine-dependent human leukemic cell line F-36: a parental line requiring granulocyte-macrophage colony-stimulating factor or interleukin-3, and a subline requiring erythropoietin. |journal=Blood |date=1 November 1991 |volume=78 |issue=9 |pages=2261–8 |doi=10.1182/blood.V78.9.2261.2261 |pmid=1834251|doi-access=free }}</ref> || [https://www.cellosaurus.org/CVCL_2037 CVCL_2037] |
|||
|- |
|||
| [[HEL cell line|HEL]] || Male || 30Y || <ref name=HEL>{{cite journal |last1=Martin |first1=P |last2=Papayannopoulou |first2=T |title=HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression. |journal=Science |date=1982-06-11 |volume=216 |issue=4551 |pages=1233–5 |doi=10.1126/science.6177045 |pmid=6177045|bibcode=1982Sci...216.1233M }}</ref> || [https://www.cellosaurus.org/CVCL_0001 CVCL_0001] |
|||
|- |
|||
| [[OCI-M2]] || unspecified || 56Y || <ref>{{cite journal |last1=Papayannopoulou |first1=T |last2=Nakamoto |first2=B |last3=Kurachi |first3=S |last4=Tweeddale |first4=M |last5=Messner |first5=H |title=Surface antigenic profile and globin phenotype of two new human erythroleukemia lines: characterization and interpretations. |journal=Blood |date=September 1988 |volume=72 |issue=3 |pages=1029–38 |doi=10.1182/blood.V72.3.1029.bloodjournal7231029 |pmid=3166384|doi-access=free }}</ref> || [https://web.expasy.org/cellosaurus/CVCL_2150 CVCL_2150] |
|||
|- |
|||
| [[TF-1 cell|TF-1]] || Male || 35Y || <ref>{{cite journal |last1=Kitamura |first1=T |last2=Tange |first2=T |last3=Terasawa |first3=T |last4=Chiba |first4=S |last5=Kuwaki |first5=T |last6=Miyagawa |first6=K |last7=Piao |first7=YF |last8=Miyazono |first8=K |last9=Urabe |first9=A |last10=Takaku |first10=F |title=Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. |journal=Journal of Cellular Physiology |date=August 1989 |volume=140 |issue=2 |pages=323–34 |doi=10.1002/jcp.1041400219 |pmid=2663885|s2cid=44794601 }}</ref> || [https://www.cellosaurus.org/CVCL_0559 CVCL_0559] |
|||
|} |
|||
===AML megakaryocytic=== |
|||
{| class="wikitable sortable" |
|||
! Cell line !! Sex !! Age !! Ref !! [[Cellosaurus]] |
|||
|- |
|||
| [[CMK (cell line)|CMK]] || Male || 10M || <ref>{{cite journal |last1=Sato |first1=T |last2=Fuse |first2=A |last3=Eguchi |first3=M |last4=Hayashi |first4=Y |last5=Ryo |first5=R |last6=Adachi |first6=M |last7=Kishimoto |first7=Y |last8=Teramura |first8=M |last9=Mizoguchi |first9=H |last10=Shima |first10=Y |title=Establishment of a human leukaemic cell line (CMK) with megakaryocytic characteristics from a Down's syndrome patient with acute megakaryoblastic leukaemia. |journal=British Journal of Haematology |date=June 1989 |volume=72 |issue=2 |pages=184–90 |doi=10.1111/j.1365-2141.1989.tb07681.x |pmid=2527057|s2cid=9036646 }}</ref><ref name=UT-7/> || [https://www.cellosaurus.org/CVCL_0216 CVCL_0216] |
|||
|- |
|||
| [[ELF-153]] || Male || 41Y || <ref>{{cite journal |last1=Mouthon |first1=MA |last2=Freund |first2=M |last3=Titeux |first3=M |last4=Katz |first4=A |last5=Guichard |first5=J |last6=Breton-Gorius |first6=J |last7=Vainchenker |first7=W |title=Growth and differentiation of the human megakaryoblastic cell line (ELF-153): a model for early stages of megakaryocytopoiesis. |journal=Blood |date=15 August 1994 |volume=84 |issue=4 |pages=1085–97 |doi=10.1182/blood.V84.4.1085.1085 |pmid=7519473|doi-access=free }}</ref> || [https://www.cellosaurus.org/CVCL_2031 CVCL_2031] |
|||
|- |
|||
| [[M-07e]] || Female || 6M || <ref>{{cite journal |last1=Avanzi |first1=GC |last2=Brizzi |first2=MF |last3=Giannotti |first3=J |last4=Ciarletta |first4=A |last5=Yang |first5=YC |last6=Pegoraro |first6=L |last7=Clark |first7=SC |title=M-07e human leukemic factor-dependent cell line provides a rapid and sensitive bioassay for the human cytokines GM-CSF and IL-3. |journal=Journal of Cellular Physiology |date=December 1990 |volume=145 |issue=3 |pages=458–64 |doi=10.1002/jcp.1041450310 |pmid=2273055|s2cid=39079797 }}</ref> || [https://www.cellosaurus.org/CVCL_2106 CVCL_2106] |
|||
|- |
|||
| [[MEGAL (cell line)|MEGAL]] || Female || unspecified || <ref name="JAK2 V617F tyrosine kinase mutation">{{cite journal |last1=Quentmeier |first1=H |last2=MacLeod |first2=RA |last3=Zaborski |first3=M |last4=Drexler |first4=HG |title=JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders. |journal=Leukemia |date=March 2006 |volume=20 |issue=3 |pages=471–6 |doi=10.1038/sj.leu.2404081 |pmid=16408098|s2cid=1907521 }}</ref> || [https://www.cellosaurus.org/CVCL_1833 CVCL_1833] |
|||
|- |
|||
| [[MKPL-1]] || Male || 66Y || <ref>{{cite journal |last1=Takeuchi |first1=S |last2=Sugito |first2=S |last3=Uemura |first3=Y |last4=Miyagi |first4=T |last5=Kubonishi |first5=I |last6=Taguchi |first6=H |last7=Enzan |first7=H |last8=Ohtsuki |first8=Y |last9=Miyoshi |first9=I |title=Acute megakaryoblastic leukemia: establishment of a new cell line (MKPL-1) in vitro and in vivo. |journal=Leukemia |date=June 1992 |volume=6 |issue=6 |pages=588–94 |pmid=1602796}}</ref> || [https://www.cellosaurus.org/CVCL_2116 CVCL_2116] |
|||
|- |
|||
| [[UT-7]] || Male || 64Y || <ref name=UT-7>{{cite journal |last1=Miura |first1=Y |last2=Komatsu |first2=N |last3=Suda |first3=T |title=Growth and differentiation of two human megakaryoblastic cell lines; CMK and UT-7. |journal=Progress in Clinical and Biological Research |date=1990 |volume=356 |pages=259–70 |pmid=2217443}}</ref> || [https://www.cellosaurus.org/CVCL_2233 CVCL_2233] |
|||
|} |
|||
===CML myeloid BC=== |
|||
{| class="wikitable sortable" |
|||
! Cell line !! Sex !! Age !! Ref !! [[Cellosaurus]] |
|||
|- |
|||
| [[EM-2 (cell line)|EM-2]] || Female || 5Y || <ref>{{cite journal |last1=Raskind |first1=WH |last2=Disteche |first2=CM |last3=Keating |first3=A |last4=Singer |first4=JW |title=Correlation between cytogenetic and molecular findings in human chronic myelogenous leukemia lines EM-2 and EM-3. |journal=Cancer Genetics and Cytogenetics |date=April 1987 |volume=25 |issue=2 |pages=271–84 |doi=10.1016/0165-4608(87)90188-9 |pmid=3030532}}</ref> || [https://www.cellosaurus.org/CVCL_1196 CVCL_1196] |
|||
|- |
|||
| [[K562 cells|K-562]] || Female || 53Y || <ref name="lozzio75"> |
|||
{{cite journal | vauthors = Lozzio CB, Lozzio BB | title = Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome | journal = Blood | volume = 45 | issue = 3 | pages = 321–334 | date = March 1975 | doi = 10.1182/blood.V45.3.321.321 | pmid = 163658 | doi-access = free }}</ref><ref name="drexler2000">{{cite book | vauthors = Drexler HG | title = The Leukemia-Lymphoma Cell Line Factsbook | place = San Diego | publisher = Academic Press | year = 2000 }}</ref> || [https://www.cellosaurus.org/CVCL_0004 CVCL_0004] |
|||
|- |
|||
| [[KCL-22]] || Female || 32Y || <ref>{{cite journal |last1=Kubonishi |first1=I |last2=Miyoshi |first2=I |title=Establishment of a Ph1 chromosome-positive cell line from chronic myelogenous leukemia in blast crisis. |journal=International Journal of Cell Cloning |date=June 1983 |volume=1 |issue=2 |pages=105–17 |doi=10.1002/stem.5530010205 |pmid=6321612}}</ref> || [https://www.cellosaurus.org/CVCL_2091 CVCL_2091] |
|||
|- |
|||
| [[Ku812]] || Male || 38Y || <ref>{{cite journal |last1=Kishi |first1=K |title=A new leukemia cell line with Philadelphia chromosome characterized as basophil precursors. |journal=Leukemia Research |date=1985 |volume=9 |issue=3 |pages=381–90 |doi=10.1016/0145-2126(85)90060-8 |pmid=3858609}}</ref> || [https://www.cellosaurus.org/CVCL_0379 CVCL_0379] |
|||
|- |
|||
| [[LAMA-84]] || Female || 29Y || <ref>{{cite journal |last1=Seigneurin |first1=D |last2=Champelovier |first2=P |last3=Mouchiroud |first3=G |last4=Berthier |first4=R |last5=Leroux |first5=D |last6=Prenant |first6=M |last7=McGregor |first7=J |last8=Starck |first8=J |last9=Morle |first9=F |last10=Micouin |first10=C |title=Human chronic myeloid leukemic cell line with positive Philadelphia chromosome exhibits megakaryocytic and erythroid characteristics. |journal=Experimental Hematology |date=September 1987 |volume=15 |issue=8 |pages=822–32 |pmid=3476310}}</ref> || [https://www.cellosaurus.org/CVCL_0388 CVCL_0388] |
|||
|- |
|||
| [[MOLM-20]] || Female || 63Y || <ref name="JAK2 V617F tyrosine kinase mutation"/> || [https://www.cellosaurus.org/CVCL_2121 CVCL_2121] |
|||
|} |
|||
===CML lymphoid BC=== |
|||
{| class="wikitable sortable" |
|||
! Cell line !! Sex !! Age !! Ref !! [[Cellosaurus]] |
|||
|- |
|||
| [[BV-173]] || Male || 45Y || <ref>{{cite journal |last1=Pegoraro |first1=L |last2=Matera |first2=L |last3=Ritz |first3=J |last4=Levis |first4=A |last5=Palumbo |first5=A |last6=Biagini |first6=G |title=Establishment of a Ph1-positive human cell line (BV173). |journal=Journal of the National Cancer Institute |date=March 1983 |volume=70 |issue=3 |pages=447–53 |pmid=6572735}}</ref> || [https://www.cellosaurus.org/CVCL_0181 CVCL_0181] |
|||
|- |
|||
| [[CML-T1]] || Female || 36Y || <ref>{{cite journal |last1=Kuriyama |first1=K |last2=Gale |first2=RP |last3=Tomonaga |first3=M |last4=Ikeda |first4=S |last5=Yao |first5=E |last6=Klisak |first6=I |last7=Whelan |first7=K |last8=Yakir |first8=H |last9=Ichimaru |first9=M |last10=Sparkes |first10=RS |title=CML-T1: a cell line derived from T-lymphocyte acute phase of chronic myelogenous leukemia. |journal=Blood |date=September 1989 |volume=74 |issue=4 |pages=1381–7 |doi=10.1182/blood.V74.4.1381.1381 |pmid=2788468|s2cid=16883925 |doi-access=free }}</ref> || [https://www.cellosaurus.org/CVCL_1126 CVCL_1126] |
|||
|- |
|||
| [[NALM-1]] || Female || 3Y || <ref>{{cite journal |last1=Minowada |first1=J |last2=Tsubota |first2=T |last3=Greaves |first3=MF |last4=Walters |first4=TR |title=A non-T, non-B human leukemia cell line (NALM-1): establishment of the cell line and presence of leukemia-associated antigens. |journal=Journal of the National Cancer Institute |date=July 1977 |volume=59 |issue=1 |pages=83–7 |doi=10.1093/jnci/59.1.83 |pmid=301573}}</ref> || [https://www.cellosaurus.orgCVCL_0091 CVCL_0091] |
|||
|- |
|||
| [[TK-6]] || Male || 30Y || <ref>{{cite journal |last1=Watanabe |first1=T |last2=Kataoka |first2=T |last3=Mizuta |first3=S |last4=Kobayashi |first4=M |last5=Uchida |first5=T |last6=Imai |first6=K |last7=Wada |first7=H |last8=Kinoshita |first8=T |last9=Murate |first9=T |last10=Mizutani |first10=S |title=Establishment and characterization of a novel cell line, TK-6, derived from T cell blast crisis of chronic myelogenous leukemia, with the secretion of parathyroid hormone-related protein. |journal=Leukemia |date=November 1995 |volume=9 |issue=11 |pages=1926–34 |pmid=7475285}}</ref> || [https://www.cellosaurus.org/CVCL_X907 CVCL_X907] |
|||
|} |
|||
===[[Myeloproliferative neoplasm|MPN]]=== |
|||
{| class="wikitable sortable" |
|||
! Cell line !! Sex !! Age !! Ref !! [[Cellosaurus]] |
|||
|- |
|||
| [[SET-2]] || Female || 71Y || <ref>{{cite journal |last1=Uozumi |first1=K |last2=Otsuka |first2=M |last3=Ohno |first3=N |last4=Moriyama |first4=T |last5=Suzuki |first5=S |last6=Shimotakahara |first6=S |last7=Matsumura |first7=I |last8=Hanada |first8=S |last9=Arima |first9=T |title=Establishment and characterization of a new human megakaryoblastic cell line (SET-2) that spontaneously matures to megakaryocytes and produces platelet-like particles. |journal=Leukemia |date=January 2000 |volume=14 |issue=1 |pages=142–52 |doi=10.1038/sj.leu.2401608 |pmid=10637490|s2cid=3258153 }}</ref> || [https://www.cellosaurus.org/CVCL_2187 CVCL_2187] |
|||
|} |
|} |
||
2024年2月2日 (五) 04:58的版本
LL-100是100种人类淋巴瘤（Lymphoma）与白血病（Leukemia）细胞系的列表[1]，用于药物筛选等许多生物医学研究[2]。
细胞系
Pre-B-ALL
| Cell line | Sex | Age | Ref | Cellosaurus |
|---|---|---|---|---|
| 697 | Male | 12Y | [3] | CVCL_0079 |
| KOPN-8 | Female | 3M | [4] | CVCL_1866 |
| NALM-6 | Male | 19Y | [5] | CVCL_0092 |
| REH | Female | 15Y | [6] | CVCL_1650 |
| SEM | Female | 5Y | [7] | CVCL_0095 |
B-NHL：伯基特淋巴瘤/B-ALL
| 细胞系 | 性别 | 年龄 | 文献 | 外部链接 |
|---|---|---|---|---|
| BJAB | Female | 5Y | [8] | CVCL_5711 |
| Daudi | Male | 16Y | [9] | CVCL_0008 |
| Raji | Male | 11Y | [10] | CVCL_0511 |
| RAMOS | Male | 3Y | [11] | CVCL_0597 |
| VAL | Female | 50Y | [12] | CVCL_1819 |
B-NHL: CLL/PLL
| Cell line | Sex | Age | Ref | Cellosaurus |
|---|---|---|---|---|
| HG-3 | Male | 70Y | [13] | CVCL_Y547 |
| JVM-3 | Male | 73Y | [14] | CVCL_1320 |
| JVM-13 | Male | 60-69Y | [15] | CVCL_1318 |
| MEC-1 | Male | 61Y | [16] | CVCL_1870 |
| PGA-1 | Male | unspecified | [17] | CVCL_Y545 |
B-NHL: DLBCL ABC
| Cell line | Sex | Age | Ref | Cellosaurus |
|---|---|---|---|---|
| NU-DHL-1 | Male | 73Y | [18] | CVCL_1876 |
| OCI-Ly3 | Male | 52Y | [19] | CVCL_8800 |
| Ri-1 | Female | 57Y | [20] | CVCL_1885 |
| U-2932 | Female | 29Y | [21] | CVCL_1896 |
| U-2946 | Male | 52Y | [22] | CVCL_X503 |
B-NHL: DLBCL GC
| Cell line | Sex | Age | Ref | Cellosaurus |
|---|---|---|---|---|
| DoHH2 | Male | 60Y | [23] | CVCL_1179 |
| OCI-Ly7 | Male | 48Y | [19] | CVCL_1881 |
| OCI-Ly19 | Female | 27Y | [24] | CVCL_1878 |
| SU-DHL-4 | Male | 38Y | [25] | CVCL_0539 |
| SU-DHL-6 | Male | 43Y | [25] | CVCL_2206 |
| WSU-DLCL2 | Male | 41Y | [26] | CVCL_1902 |
B-NHL: HCL
| Cell line | Sex | Age | Ref | Cellosaurus |
|---|---|---|---|---|
| BONNA-12 | Male | 46Y | [27] | CVCL_1090 |
| Hair-M | Male | 86Y | [28] | CVCL_B401 |
| HC-1 | Male | 56Y | [29] | CVCL_1243 |
B-NHL: MCL
| Cell line | Sex | Age | Ref | Cellosaurus |
|---|---|---|---|---|
| Granta-519 | Female | 58Y | [30] | CVCL_1818 |
| JeKo-1 | Female | 78Y | [31] | CVCL_1865 |
| JVM-2 | Female | 63Y | [14] | CVCL_1319 |
| Mino | Male | 68Y | [32] | CVCL_1872 |
| REC-1 | Male | 61Y | [33] | CVCL_1884 |
B-NHL: PEL
| Cell line | Sex | Age | Ref | Cellosaurus |
|---|---|---|---|---|
| BC-3 | Male | 85Y | [34] | CVCL_1080 |
| BCBL-1 | Male | 40Y | [35] | CVCL_0165 |
| CRO-AP2 | Male | 49Y | [36] | CVCL_1147 |
| CRO-AP5 | Male | 35Y | [37] | CVCL_1148 |
B-NHL: PMBL
| Cell line | Sex | Age | Ref | Cellosaurus |
|---|---|---|---|---|
| U-2940 | Female | 18Y | [38] | CVCL_1897 |
Multiple Myeloma/PCL
| Cell line | Sex | Age | Ref | Cellosaurus |
|---|---|---|---|---|
| KMS-12-BM | Female | 64Y | [39] | CVCL_1334 |
| L-363 | Female | 36Y | [40] | CVCL_1357 |
| LP-1 | Female | 56Y | [41] | CVCL_0012 |
| OPM-2 | Female | 56Y | [42] | CVCL_1625 |
| RPMI-8226 | Male | 61Y | [43] | CVCL_0014 |
| U-266 | Male | 53Y | [44] | CVCL_0566 |
Hodgkin Lymphoma
| Cell line | Sex | Age | Ref | Cellosaurus |
|---|---|---|---|---|
| HDLM-2 | Male | 74Y | [45] | CVCL_0009 |
| KM-H2 | Male | 37Y | [46] | CVCL_1330 |
| L-428 | Female | 37Y | [45] | CVCL_1361 |
| L-1236 | Male | 34Y | [47] | CVCL_2096 |
| SUP-HD1 | Male | 37Y | [48] | CVCL_2208 |
T-ALL/T-LL
| Cell line | Sex | Age | Ref | Cellosaurus |
|---|---|---|---|---|
| CCRF-CEM | Female | 3Y11M | [49] | CVCL_0207 |
| DND-41 | Male | 13Y | [50] | CVCL_2022 |
| HPB-ALL | Male | 14Y | [51] | CVCL_1820 |
| Jurkat | Male | 14Y | [52] | CVCL_0065 |
| MOLT-4 | Male | 19Y | [53] | CVCL_0013 |
| RPMI-8402 | Female | 16Y | [54] | CVCL_1667 |
Mature T-Malignancy
| Cell line | Sex | Age | Ref | Cellosaurus |
|---|---|---|---|---|
| DERL-7 | Male | 30Y | [55] | CVCL_2017 |
| HH | Male | 61Y | [56] | CVCL_1280 |
| MOTN-1 | Female | 65Y | [57] | CVCL_2127 |
NK Malignancy
| Cell line | Sex | Age | Ref | Cellosaurus |
|---|---|---|---|---|
| KHYG-1 | Female | 45Y | [58] | CVCL_2976 |
| NK-92 | Male | 50Y | [59] | CVCL_2142 |
| YT | Male | 15Y | [60] | CVCL_1797 |
ALCL
| Cell line | Sex | Age | Ref | Cellosaurus |
|---|---|---|---|---|
| DEL | Male | 12Y | [61] | CVCL_1170 |
| SR-786 | Male | 11Y | [62] | CVCL_1711 |
| SU-DHL-1 | Male | 10Y | [63] | CVCL_0538 |
| SUP-M2 | Female | 5Y | [64] | CVCL_2209 |
AML myelocytic
| Cell line | Sex | Age | Ref | Cellosaurus |
|---|---|---|---|---|
| EoL-1 | Male | 33Y | [65] | CVCL_0258 |
| HL-60 | Female | 36Y | [66] | CVCL_0002 |
| Kasumi-1 | Male | 7Y | [67] | CVCL_0589 |
| KG-1 | Male | 59Y | [68] | CVCL_0374 |
| NB4 | Female | 23Y | [69] | CVCL_0005 |
| OCI-AML3 | Male | 57Y | [70] | CVCL_1844 |
| SKNO-1 | Male | 22Y | [71] | CVCL_2196 |
AML monocytic
| Cell line | Sex | Age | Ref | Cellosaurus |
|---|---|---|---|---|
| ME-1 | Male | 40Y | [72] | CVCL_2110 |
| MOLM-13 | Male | 20Y | [73] | CVCL_2119 |
| Mono-Mac-6 | Male | 64Y | [74] | CVCL_1426 |
| MUTZ-3 | Male | 29Y | [75] | CVCL_1433 |
| THP-1 | Male | 1Y | [76] | CVCL_0006 |
| U-937 | Male | 37Y | [77] | CVCL_0007 |
AML erythroid
| Cell line | Sex | Age | Ref | Cellosaurus |
|---|---|---|---|---|
| F-36P | Male | 68Y | [78] | CVCL_2037 |
| HEL | Male | 30Y | [79] | CVCL_0001 |
| OCI-M2 | unspecified | 56Y | [80] | CVCL_2150 |
| TF-1 | Male | 35Y | [81] | CVCL_0559 |
AML megakaryocytic
| Cell line | Sex | Age | Ref | Cellosaurus |
|---|---|---|---|---|
| CMK | Male | 10M | [82][83] | CVCL_0216 |
| ELF-153 | Male | 41Y | [84] | CVCL_2031 |
| M-07e | Female | 6M | [85] | CVCL_2106 |
| MEGAL | Female | unspecified | [86] | CVCL_1833 |
| MKPL-1 | Male | 66Y | [87] | CVCL_2116 |
| UT-7 | Male | 64Y | [83] | CVCL_2233 |
CML myeloid BC
| Cell line | Sex | Age | Ref | Cellosaurus |
|---|---|---|---|---|
| EM-2 | Female | 5Y | [88] | CVCL_1196 |
| K-562 | Female | 53Y | [89][90] | CVCL_0004 |
| KCL-22 | Female | 32Y | [91] | CVCL_2091 |
| Ku812 | Male | 38Y | [92] | CVCL_0379 |
| LAMA-84 | Female | 29Y | [93] | CVCL_0388 |
| MOLM-20 | Female | 63Y | [86] | CVCL_2121 |
CML lymphoid BC
| Cell line | Sex | Age | Ref | Cellosaurus |
|---|---|---|---|---|
| BV-173 | Male | 45Y | [94] | CVCL_0181 |
| CML-T1 | Female | 36Y | [95] | CVCL_1126 |
| NALM-1 | Female | 3Y | [96] | CVCL_0091 |
| TK-6 | Male | 30Y | [97] | CVCL_X907 |
MPN
| Cell line | Sex | Age | Ref | Cellosaurus |
|---|---|---|---|---|
| SET-2 | Female | 71Y | [98] | CVCL_2187 |
另见
- NCI-60，国家癌症研究所（NCI）列出的60种人类癌细胞系列表
- List of breast cancer cell lines
参考文献
- ^ Quentmeier, H; Pommerenke, C; Dirks, WG; Eberth, S; Koeppel, M; MacLeod, RAF; Nagel, S; Steube, K; Uphoff, CC; Drexler, HG. The LL-100 panel: 100 cell lines for blood cancer studies.. Scientific Reports. 3 June 2019, 9 (1): 8218. Bibcode:2019NatSR...9.8218Q. PMC 6547646
. PMID 31160637. doi:10.1038/s41598-019-44491-x.
- ^ Drexler, HG; Quentmeier, H. The LL-100 Cell Lines Panel: Tool for Molecular Leukemia-Lymphoma Research.. International Journal of Molecular Sciences. 13 August 2020, 21 (16): 5800. PMC 7461097 . PMID 32823535. doi:10.3390/ijms21165800 .
- ^ Findley HW, Jr; Cooper, MD; Kim, TH; Alvarado, C; Ragab, AH. Two new acute lymphoblastic leukemia cell lines with early B-cell phenotypes.. Blood. December 1982, 60 (6): 1305–9. PMID 6982733. doi:10.1182/blood.V60.6.1305.1305 .
- ^ Uphoff, CC; MacLeod, RA; Denkmann, SA; Golub, TR; Borkhardt, A; Janssen, JW; Drexler, HG. Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in human early B-lineage leukemia cell lines.. Leukemia. March 1997, 11 (3): 441–7. PMID 9067587. S2CID 37823510. doi:10.1038/sj.leu.2400571.
- ^ Hurwitz, R; Hozier, J; LeBien, T; Minowada, J; Gajl-Peczalska, K; Kubonishi, I; Kersey, J. Characterization of a leukemic cell line of the pre-B phenotype.. International Journal of Cancer. February 1979, 23 (2): 174–80. PMID 83966. S2CID 29853203. doi:10.1002/ijc.2910230206.
- ^ Rosenfeld, C; Goutner, A; Venuat, AM; Choquet, C; Pico, JL; Dore, JF; Liabeuf, A; Durandy, A; Desgrange, C; De The, G. An effect human leukaemic cell line: Reh.. European Journal of Cancer. April 1977, 13 (4–5): 377–9. PMID 194778. doi:10.1016/0014-2964(77)90085-8.
- ^ Greil, J; Gramatzki, M; Burger, R; Marschalek, R; Peltner, M; Trautmann, U; Hansen-Hagge, TE; Bartram, CR; Fey, GH; Stehr, K. The acute lymphoblastic leukaemia cell line SEM with t(4;11) chromosomal rearrangement is biphenotypic and responsive to interleukin-7.. British Journal of Haematology. February 1994, 86 (2): 275–83. PMID 8199015. S2CID 44321104. doi:10.1111/j.1365-2141.1994.tb04726.x.
- ^ Menezes, J; Leibold, W; Klein, G; Clements, G. Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.. Biomédicine. July 1975, 22 (4): 276–84. PMID 179629.
- ^ Nadkarni, JS; Nadkarni, JJ; Clifford, P; Manolov, G; Fenyö, EM; Klein, E. Characteristics of new cell lines derived from Burkitt lymphomas.. Cancer. January 1969, 23 (1): 64–79. PMID 4178827. S2CID 46405882. doi:10.1002/1097-0142(196901)23:1<64::aid-cncr2820230107>3.0.co;2-m .
- ^ PULVERTAFT, JV. Cytology of Burkitt's Tumour (African Lymphoma). Lancet. 1 February 1964, 1 (7327): 238–40. PMID 14086209. doi:10.1016/s0140-6736(64)92345-1.
- ^ Klein, G; Giovanella, B; Westman, A; Stehlin, JS; Mumford, D. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection.. Intervirology. 1975, 5 (6): 319–34. PMID 181343. doi:10.1159/000149930.
- ^ Kerckaert, JP; Deweindt, C; Tilly, H; Quief, S; Lecocq, G; Bastard, C. LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas.. Nature Genetics. September 1993, 5 (1): 66–70. PMID 8220427. S2CID 12575122. doi:10.1038/ng0993-66.
- ^ Rosén, A; Bergh, AC; Gogok, P; Evaldsson, C; Myhrinder, AL; Hellqvist, E; Rasul, A; Björkholm, M; Jansson, M; Mansouri, L; Liu, A; Teh, BT; Rosenquist, R; Klein, E. Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infection.. Oncoimmunology. 1 January 2012, 1 (1): 18–27. PMC 3376971 . PMID 22720208. doi:10.4161/onci.1.1.18400.
- ^ 14.0 14.1 Melo, JV; Brito-Babapulle, V; Foroni, L; Robinson, DS; Luzzatto, L; Catovsky, D. Two new cell lines from B-prolymphocytic leukaemia: characterization by morphology, immunological markers, karyotype and Ig gene rearrangement.. International Journal of Cancer. 15 October 1986, 38 (4): 531–8. PMID 3093393. S2CID 10813284. doi:10.1002/ijc.2910380413.
- ^ Melo, JV; Foroni, L; Brito-Babapulle, V; Luzzatto, L; Catovsky, D. The establishment of cell lines from chronic B cell leukaemias: evidence of leukaemic origin by karyotypic abnormalities and Ig gene rearrangement.. Clinical and Experimental Immunology. July 1988, 73 (1): 23–8. PMC 1541467 . PMID 3262465.
- ^ Stacchini, A; Aragno, M; Vallario, A; Alfarano, A; Circosta, P; Gottardi, D; Faldella, A; Rege-Cambrin, G; Thunberg, U; Nilsson, K; Caligaris-Cappio, F. MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation.. Leukemia Research. February 1999, 23 (2): 127–36. PMID 10071128. doi:10.1016/s0145-2126(98)00154-4.
- ^ Lewin, N; Aman, P; Mellstedt, H; Zech, L; Klein, G. Direct outgrowth of in vivo Epstein-Barr virus (EBV)-infected chronic lymphocytic leukemia (CLL) cells into permanent lines.. International Journal of Cancer. 15 June 1988, 41 (6): 892–5. PMID 2836321. S2CID 38575113. doi:10.1002/ijc.2910410621.
- ^ Epstein, AL; Variakojis, D; Berger, C; Hecht, BK. Use of novel chemical supplements in the establishment of three human malignant lymphoma cell lines (NU-DHL-1, NU-DUL-1, and NU-AMB-1) with chromosome 14 translocations.. International Journal of Cancer. 15 May 1985, 35 (5): 619–27. PMID 2581902. S2CID 38530935. doi:10.1002/ijc.2910350509.
- ^ 19.0 19.1 Tweeddale, ME; Lim, B; Jamal, N; Robinson, J; Zalcberg, J; Lockwood, G; Minden, MD; Messner, HA. The presence of clonogenic cells in high-grade malignant lymphoma: a prognostic factor.. Blood. May 1987, 69 (5): 1307–14. PMID 3567358. doi:10.1182/blood.V69.5.1307.1307 .
- ^ Th'ng, KH; Garewal, G; Kearney, L; Rassool, F; Melo, JV; White, H; Catovsky, D; Foroni, L; Luzzatto, L; Goldman, JM. Establishment and characterization of three new malignant lymphoid cell lines.. International Journal of Cancer. 15 January 1987, 39 (1): 89–93. PMID 3098690. S2CID 23849509. doi:10.1002/ijc.2910390116.
- ^ Amini, RM; Berglund, M; Rosenquist, R; Von Heideman, A; Lagercrantz, S; Thunberg, U; Bergh, J; Sundström, C; Glimelius, B; Enblad, G. A novel B-cell line (U-2932) established from a patient with diffuse large B-cell lymphoma following Hodgkin lymphoma.. Leukemia & Lymphoma. November 2002, 43 (11): 2179–89. PMID 12533045. S2CID 23476994. doi:10.1080/1042819021000032917.
- ^ Fridberg, M; Servin, A; Anagnostaki, L; Linderoth, J; Berglund, M; Söderberg, O; Enblad, G; Rosén, A; Mustelin, T; Jerkeman, M; Persson, JL; Wingren, AG. Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN.. Leukemia & Lymphoma. November 2007, 48 (11): 2221–32. PMID 17926183. S2CID 17523509. doi:10.1080/10428190701636443.
- ^ Kluin-Nelemans, HC; Limpens, J; Meerabux, J; Beverstock, GC; Jansen, JH; de Jong, D; Kluin, PM. A new non-Hodgkin's B-cell line (DoHH2) with a chromosomal translocation t(14;18)(q32;q21).. Leukemia. March 1991, 5 (3): 221–4. PMID 1849602.
- ^ Chang, H; Blondal, JA; Benchimol, S; Minden, MD; Messner, HA. p53 mutations, c-myc and bcl-2 rearrangements in human non-Hodgkin's lymphoma cell lines.. Leukemia & Lymphoma. September 1995, 19 (1–2): 165–71. PMID 8574164. doi:10.3109/10428199509059672.
- ^ 25.0 25.1 Epstein, AL; Herman, MM; Kim, H; Dorfman, RF; Kaplan, HS. Biology of the human malignant lymphomas. III. Intracranial heterotransplantation in the nude, athymic mouse.. Cancer. May 1976, 37 (5): 2158–76. PMID 177185. S2CID 6013844. doi:10.1002/1097-0142(197605)37:5<2158::aid-cncr2820370503>3.0.co;2-f.
- ^ Al-Katib, AM; Smith, MR; Kamanda, WS; Pettit, GR; Hamdan, M; Mohamed, AN; Chelladurai, B; Mohammad, RM. Bryostatin 1 down-regulates mdr1 and potentiates vincristine cytotoxicity in diffuse large cell lymphoma xenografts.. Clinical Cancer Research. May 1998, 4 (5): 1305–14. PMID 9607591.
- ^ Wientjens, GJ; Jansen, JH; Wessels, HW; Kibbelaar, RE; Beverstock, GC; Brederoo, P; Kluin-Nelemans, HC. Characterization of a New Human B Cell Line (Bonna-12) with Trisomy 9 and Trisomy 12 Chromosomal Abnormality.. Leukemia & Lymphoma. 1991, 5 (5–6): 415–22. PMID 27463354. doi:10.3109/10428199109067637.
- ^ Matsuo, Y; Sagawa, K; Yokoyama, M; Koga, T; Yamaguchi, T; Morita, M; Minowada, J. [Establishment and characterization of hairy cell leukemia cell line (Hair-M)].. Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society. November 1983, 46 (6): 1222–32. PMID 6608852.
- ^ Schiller, JH; Bittner, G; Meisner, LF; Oberley, TD; Norback, D; Schwabe, M; Faltynek, CR; Raab-Traub, N. Establishment and characterization of an Epstein-Barr virus spontaneously transformed lymphocytic cell line derived from a hairy cell leukemia patient.. Leukemia. May 1991, 5 (5): 399–407. PMID 1851909.
- ^ Lukas, J; Jadayel, D; Bartkova, J; Nacheva, E; Dyer, MJ; Strauss, M; Bartek, J. BCL-1/cyclin D1 oncoprotein oscillates and subverts the G1 phase control in B-cell neoplasms carrying the t(11;14) translocation.. Oncogene. August 1994, 9 (8): 2159–67. PMID 8036001.
- ^ Jeon, HJ; Kim, CW; Yoshino, T; Akagi, T. Establishment and characterization of a mantle cell lymphoma cell line.. British Journal of Haematology. September 1998, 102 (5): 1323–6. PMID 9753063. S2CID 29818033. doi:10.1046/j.1365-2141.1998.00911.x .
- ^ Lai, R; McDonnell, TJ; O'Connor, SL; Medeiros, LJ; Oudat, R; Keating, M; Morgan, MB; Curiel, TJ; Ford, RJ. Establishment and characterization of a new mantle cell lymphoma cell line, Mino.. Leukemia Research. September 2002, 26 (9): 849–55. PMID 12127561. doi:10.1016/s0145-2126(02)00013-9.
- ^ Szepetowski, P; Simon, MP; Grosgeorge, J; Huebner, K; Bastard, C; Evans, GA; Tsujimoto, Y; Birnbaum, D; Theillet, C; Gaudray, P. Localization of 11q13 loci with respect to regional chromosomal breakpoints.. Genomics. April 1992, 12 (4): 738–44. PMID 1572647. doi:10.1016/0888-7543(92)90303-a.
- ^ Arvanitakis, L; Mesri, EA; Nador, RG; Said, JW; Asch, AS; Knowles, DM; Cesarman, E. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus.. Blood. 1 October 1996, 88 (7): 2648–54. PMID 8839859. doi:10.1182/blood.V88.7.2648.bloodjournal8872648 .
- ^ Renne, R; Zhong, W; Herndier, B; McGrath, M; Abbey, N; Kedes, D; Ganem, D. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture.. Nature Medicine. March 1996, 2 (3): 342–6. PMID 8612236. S2CID 20384290. doi:10.1038/nm0396-342.
- ^ Carbone, A; Cilia, AM; Gloghini, A; Canzonieri, V; Pastore, C; Todesco, M; Cozzi, M; Perin, T; Volpe, R; Pinto, A; Gaidano, G. Establishment of HHV-8-positive and HHV-8-negative lymphoma cell lines from primary lymphomatous effusions.. International Journal of Cancer. 14 November 1997, 73 (4): 562–9. PMID 9389573. S2CID 32367275. doi:10.1002/(sici)1097-0215(19971114)73:4<562::aid-ijc18>3.0.co;2-b.
- ^ Carbone, A; Cilia, AM; Gloghini, A; Capello, D; Todesco, M; Quattrone, S; Volpe, R; Gaidano, G. Establishment and characterization of EBV-positive and EBV-negative primary effusion lymphoma cell lines harbouring human herpesvirus type-8.. British Journal of Haematology. September 1998, 102 (4): 1081–9. PMID 9734661. S2CID 23440348. doi:10.1046/j.1365-2141.1998.00877.x .
- ^ Sambade, C; Berglund, M; Lagercrantz, S; Sällström, J; Reis, RM; Enblad, G; Glimelius, B; Sundström, C. U-2940, a human B-cell line derived from a diffuse large cell lymphoma sequential to Hodgkin lymphoma.. International Journal of Cancer. 1 February 2006, 118 (3): 555–63. PMID 16106419. S2CID 12837372. doi:10.1002/ijc.21417 .
- ^ Ohtsuki, T; Yawata, Y; Wada, H; Sugihara, T; Mori, M; Namba, M. Two human myeloma cell lines, amylase-producing KMS-12-PE and amylase-non-producing KMS-12-BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;q32).. British Journal of Haematology. October 1989, 73 (2): 199–204. PMID 2479409. S2CID 29676750. doi:10.1111/j.1365-2141.1989.tb00252.x.
- ^ Diehl, V; Schaadt, M; Kirchner, H; Hellriegel, KP; Gudat, F; Fonatsch, C; Laskewitz, E; Guggenheim, R. Long-term cultivation of plasma cell leukemia cells and autologous lymphoblasts (LCL) in vitro: a comparative study.. Blut. 20 June 1978, 36 (6): 331–8. PMID 207377. S2CID 22828123. doi:10.1007/BF01000590.
- ^ Pegoraro, L; Malavasi, F; Bellone, G; Massaia, M; Boccadoro, M; Saglio, G; Guerrasio, A; Benetton, G; Lombardi, L; Coda, R. The human myeloma cell line LP-1: a versatile model in which to study early plasma-cell differentiation and c-myc activation.. Blood. March 1989, 73 (4): 1020–7. PMID 2784066. doi:10.1182/blood.V73.4.1020.1020 .
- ^ Katagiri, S; Yonezawa, T; Kuyama, J; Kanayama, Y; Nishida, K; Abe, T; Tamaki, T; Ohnishi, M; Tarui, S. Two distinct human myeloma cell lines originating from one patient with myeloma.. International Journal of Cancer. 15 August 1985, 36 (2): 241–6. PMID 3926660. S2CID 20506312. doi:10.1002/ijc.2910360217.
- ^ Matsuoka, Y; Moore, GE; Yagi, Y; Pressman, D. Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma.. Proceedings of the Society for Experimental Biology and Medicine. August 1967, 125 (4): 1246–50. PMID 6042436. S2CID 9643262. doi:10.3181/00379727-125-32327.
- ^ Nilsson, K; Bennich, H; Johansson, SG; Pontén, J. Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient.. Clinical and Experimental Immunology. October 1970, 7 (4): 477–89. PMC 1712861 . PMID 4097745.
- ^ 45.0 45.1 Drexler, HG; Gaedicke, G; Lok, MS; Diehl, V; Minowada, J. Hodgkin's disease derived cell lines HDLM-2 and L-428: comparison of morphology, immunological and isoenzyme profiles.. Leukemia Research. 1986, 10 (5): 487–500. PMID 3713248. doi:10.1016/0145-2126(86)90084-6.
- ^ Kamesaki, H; Fukuhara, S; Tatsumi, E; Uchino, H; Yamabe, H; Miwa, H; Shirakawa, S; Hatanaka, M; Honjo, T. Cytochemical, immunologic, chromosomal, and molecular genetic analysis of a novel cell line derived from Hodgkin's disease.. Blood. July 1986, 68 (1): 285–92. PMID 3013343. doi:10.1182/blood.V68.1.285.285 .
- ^ Wolf, J; Kapp, U; Bohlen, H; Kornacker, M; Schoch, C; Stahl, B; Mücke, S; von Kalle, C; Fonatsch, C; Schaefer, HE; Hansmann, ML; Diehl, V. Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells.. Blood. 15 April 1996, 87 (8): 3418–28. PMID 8605360. doi:10.1182/blood.V87.8.3418.bloodjournal8783418 .
- ^ Naumovski, L; Utz, PJ; Bergstrom, SK; Morgan, R; Molina, A; Toole, JJ; Glader, BE; McFall, P; Weiss, LM; Warnke, R. SUP-HD1: a new Hodgkin's disease-derived cell line with lymphoid features produces interferon-gamma.. Blood. December 1989, 74 (8): 2733–42. PMID 2554995. doi:10.1182/blood.V74.8.2733.2733 .
- ^ FOLEY, GE; LAZARUS, H; FARBER, S; UZMAN, BG; BOONE, BA; MCCARTHY, RE. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer. April 1965, 18 (4): 522–9. PMID 14278051. S2CID 32647486. doi:10.1002/1097-0142(196504)18:4<522::aid-cncr2820180418>3.0.co;2-j .
- ^ Heyman, M; Grandér, D; Bröndum-Nielsen, K; Cederblad, B; Liu, Y; Xu, B; Einhorn, S. Interferon system defects in malignant T-cells.. Leukemia. March 1994, 8 (3): 425–34. PMID 8127147.
- ^ Morikawa, S; Tatsumi, E; Baba, M; Harada, T; Yasuhira, K. Two E-rosette-forming lymphoid cell lines.. International Journal of Cancer. 15 February 1978, 21 (2): 166–70. PMID 203546. S2CID 9032666. doi:10.1002/ijc.2910210207.
- ^ Abraham, RT; Weiss, A. Jurkat T cells and development of the T-cell receptor signalling paradigm.. Nature Reviews. Immunology. April 2004, 4 (4): 301–8. PMID 15057788. S2CID 13253575. doi:10.1038/nri1330.
- ^ Minowada, J; Onuma, T; Moore, GE. Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.. Journal of the National Cancer Institute. September 1972, 49 (3): 891–5. PMID 4567231.
- ^ Huang, CC; Hou, Y; Woods, LK; Moore, GE; Minowada, J. Cytogenetic study of human lymphoid T-cell lines derived from lymphocytic leukemia.. Journal of the National Cancer Institute. September 1974, 53 (3): 655–60. PMID 4547172. doi:10.1093/jnci/53.3.655.
- ^ Di Noto, R; Pane, F; Camera, A; Luciano, L; Barone, M; Lo Pardo, C; Boccuni, P; Intrieri, M; Izzo, B; Villa, MR; Macrí, M; Rotoli, B; Sacchetti, L; Salvatore, F; Del Vecchio, L. Characterization of two novel cell lines, DERL-2 (CD56+/CD3+/Tcry5+) and DERL-7 (CD56+/CD3-/TCRgammadelta-), derived from a single patient with CD56+ non-Hodgkin's lymphoma.. Leukemia. October 2001, 15 (10): 1641–9. PMID 11587224. S2CID 25177712. doi:10.1038/sj.leu.2402239.
- ^ Starkebaum, G; Loughran TP, Jr; Waters, CA; Ruscetti, FW. Establishment of an IL-2 independent, human T-cell line possessing only the p70 IL-2 receptor.. International Journal of Cancer. 9 September 1991, 49 (2): 246–53. PMID 1879969. S2CID 8605186. doi:10.1002/ijc.2910490218.
- ^ Matsuo, Y; Drexler, HG; Takeuchi, M; Tanaka, M; Orita, K. Establishment of the T-cell large granular lymphocyte leukemia cell line MOTN-1 carrying natural killer-cell antigens.. Leukemia Research. September 2002, 26 (9): 873–9. PMID 12127564. doi:10.1016/s0145-2126(02)00023-1.
- ^ Yagita, M; Huang, CL; Umehara, H; Matsuo, Y; Tabata, R; Miyake, M; Konaka, Y; Takatsuki, K. A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation.. Leukemia. May 2000, 14 (5): 922–30. PMID 10803526. S2CID 22938275. doi:10.1038/sj.leu.2401769.
- ^ Gong, J., Maki, G., and Klingemann, H-G. (1994). “Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells”. Leukemia; 8: 652-58.
- ^ Yodoi, J; Teshigawara, K; Nikaido, T; Fukui, K; Noma, T; Honjo, T; Takigawa, M; Sasaki, M; Minato, N; Tsudo, M. TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells).. Journal of Immunology. March 1985, 134 (3): 1623–30. PMID 2578514. S2CID 13147698. doi:10.4049/jimmunol.134.3.1623 .
- ^ Barbey, S; Gogusev, J; Mouly, H; Le Pelletier, O; Smith, W; Richard, S; Soulie, J; Nezelof, C. DEL cell line: a "malignant histiocytosis" CD30+ t(5;6)(q35;p21) cell line.. International Journal of Cancer. 15 March 1990, 45 (3): 546–53. PMID 2307542. S2CID 1472373. doi:10.1002/ijc.2910450329.
- ^ Su, IJ; Balk, SP; Kadin, ME. Molecular basis for the aberrant expression of T cell antigens in postthymic T cell malignancies.. The American Journal of Pathology. August 1988, 132 (2): 192–8. PMC 1880737 . PMID 2456698.
- ^ Epstein, AL; Kaplan, HS. Biology of the human malignant lymphomas. I. Establishment in continuous cell culture and heterotransplantation of diffuse histiocytic lymphomas.. Cancer. December 1974, 34 (6): 1851–72. PMID 4140017. S2CID 27701046. doi:10.1002/1097-0142(197412)34:6<1851::aid-cncr2820340602>3.0.co;2-4 .
- ^ Morgan, R; Smith, SD; Hecht, BK; Christy, V; Mellentin, JD; Warnke, R; Cleary, ML. Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5)(p23;q35) common to malignancies with features of so-called malignant histiocytosis.. Blood. June 1989, 73 (8): 2155–64. PMID 2525056. doi:10.1182/blood.V73.8.2155.2155 .
- ^ Mayumi, M. EoL-1, a human eosinophilic cell line.. Leukemia & Lymphoma. June 1992, 7 (3): 243–50 [2019-12-23]. PMID 1477652. doi:10.3109/10428199209053629. （原始内容存档于2019-12-23）.
- ^ Gallagher, R; Collins, S; Trujillo, J; McCredie, K; Ahearn, M; Tsai, S; Metzgar, R; Aulakh, G; Ting, R; Ruscetti, F; Gallo, R. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia.. Blood. September 1979, 54 (3): 713–33. PMID 288488. doi:10.1182/blood.V54.3.713.713 .
- ^ Asou, H; Tashiro, S; Hamamoto, K; Otsuji, A; Kita, K; Kamada, N. Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation.. Blood. 1 May 1991, 77 (9): 2031–6. PMID 2018839. doi:10.1182/blood.V77.9.2031.2031 .
- ^ Mrózek, K; Tanner, SM; Heinonen, K; Bloomfield, CD. Molecular cytogenetic characterization of the KG-1 and KG-1a acute myeloid leukemia cell lines by use of spectral karyotyping and fluorescence in situ hybridization.. Genes, Chromosomes & Cancer. November 2003, 38 (3): 249–52. PMID 14506699. S2CID 6018408. doi:10.1002/gcc.10274 .
- ^ Lanotte, M; Martin-Thouvenin, V; Najman, S; Balerini, P; Valensi, F; Berger, R. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3).. Blood. 1 March 1991, 77 (5): 1080–6. PMID 1995093. doi:10.1182/blood.V77.5.1080.1080 .
- ^ Wang, C; Curtis, JE; Minden, MD; McCulloch, EA. Expression of a retinoic acid receptor gene in myeloid leukemia cells.. Leukemia. April 1989, 3 (4): 264–9. PMID 2538684.
- ^ Matozaki, S; Nakagawa, T; Kawaguchi, R; Aozaki, R; Tsutsumi, M; Murayama, T; Koizumi, T; Nishimura, R; Isobe, T; Chihara, K. Establishment of a myeloid leukaemic cell line (SKNO-1) from a patient with t(8;21) who acquired monosomy 17 during disease progression.. British Journal of Haematology. April 1995, 89 (4): 805–11. PMID 7772516. S2CID 40610063. doi:10.1111/j.1365-2141.1995.tb08418.x.
- ^ Yanagisawa, K; Horiuchi, T; Fujita, S. Establishment and characterization of a new human leukemia cell line derived from M4E0.. Blood. 15 July 1991, 78 (2): 451–7. PMID 2070080. doi:10.1182/blood.V78.2.451.451 .
- ^ Matsuo, Y; MacLeod, RA; Uphoff, CC; Drexler, HG; Nishizaki, C; Katayama, Y; Kimura, G; Fujii, N; Omoto, E; Harada, M; Orita, K. Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins(11;9)(q23;p22p23).. Leukemia. September 1997, 11 (9): 1469–77. PMID 9305600. S2CID 205678428. doi:10.1038/sj.leu.2400768.
- ^ Ziegler-Heitbrock, HW; Thiel, E; Fütterer, A; Herzog, V; Wirtz, A; Riethmüller, G. Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes.. International Journal of Cancer. 15 March 1988, 41 (3): 456–61. PMID 3162233. S2CID 23268646. doi:10.1002/ijc.2910410324.
- ^ Hu, ZB; Ma, W; Zaborski, M; MacLeod, R; Quentmeier, H; Drexler, HG. Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3.. Leukemia. June 1996, 10 (6): 1025–40. PMID 8667638.
- ^ Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). International Journal of Cancer. August 1980, 26 (2): 171–6. PMID 6970727. S2CID 43603660. doi:10.1002/ijc.2910260208.
- ^ Sundström C. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int. J. Cancer. May 1976, 17 (5): 565–77. PMID 178611. S2CID 19334036. doi:10.1002/ijc.2910170504.
- ^ Chiba, S; Takaku, F; Tange, T; Shibuya, K; Misawa, C; Sasaki, K; Miyagawa, K; Yazaki, Y; Hirai, H. Establishment and erythroid differentiation of a cytokine-dependent human leukemic cell line F-36: a parental line requiring granulocyte-macrophage colony-stimulating factor or interleukin-3, and a subline requiring erythropoietin.. Blood. 1 November 1991, 78 (9): 2261–8. PMID 1834251. doi:10.1182/blood.V78.9.2261.2261 .
- ^ Martin, P; Papayannopoulou, T. HEL cells: a new human erythroleukemia cell line with spontaneous and induced globin expression.. Science. 1982-06-11, 216 (4551): 1233–5. Bibcode:1982Sci...216.1233M. PMID 6177045. doi:10.1126/science.6177045.
- ^ Papayannopoulou, T; Nakamoto, B; Kurachi, S; Tweeddale, M; Messner, H. Surface antigenic profile and globin phenotype of two new human erythroleukemia lines: characterization and interpretations.. Blood. September 1988, 72 (3): 1029–38. PMID 3166384. doi:10.1182/blood.V72.3.1029.bloodjournal7231029 .
- ^ Kitamura, T; Tange, T; Terasawa, T; Chiba, S; Kuwaki, T; Miyagawa, K; Piao, YF; Miyazono, K; Urabe, A; Takaku, F. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin.. Journal of Cellular Physiology. August 1989, 140 (2): 323–34. PMID 2663885. S2CID 44794601. doi:10.1002/jcp.1041400219.
- ^ Sato, T; Fuse, A; Eguchi, M; Hayashi, Y; Ryo, R; Adachi, M; Kishimoto, Y; Teramura, M; Mizoguchi, H; Shima, Y. Establishment of a human leukaemic cell line (CMK) with megakaryocytic characteristics from a Down's syndrome patient with acute megakaryoblastic leukaemia.. British Journal of Haematology. June 1989, 72 (2): 184–90. PMID 2527057. S2CID 9036646. doi:10.1111/j.1365-2141.1989.tb07681.x.
- ^ 83.0 83.1 Miura, Y; Komatsu, N; Suda, T. Growth and differentiation of two human megakaryoblastic cell lines; CMK and UT-7.. Progress in Clinical and Biological Research. 1990, 356: 259–70. PMID 2217443.
- ^ Mouthon, MA; Freund, M; Titeux, M; Katz, A; Guichard, J; Breton-Gorius, J; Vainchenker, W. Growth and differentiation of the human megakaryoblastic cell line (ELF-153): a model for early stages of megakaryocytopoiesis.. Blood. 15 August 1994, 84 (4): 1085–97. PMID 7519473. doi:10.1182/blood.V84.4.1085.1085 .
- ^ Avanzi, GC; Brizzi, MF; Giannotti, J; Ciarletta, A; Yang, YC; Pegoraro, L; Clark, SC. M-07e human leukemic factor-dependent cell line provides a rapid and sensitive bioassay for the human cytokines GM-CSF and IL-3.. Journal of Cellular Physiology. December 1990, 145 (3): 458–64. PMID 2273055. S2CID 39079797. doi:10.1002/jcp.1041450310.
- ^ 86.0 86.1 Quentmeier, H; MacLeod, RA; Zaborski, M; Drexler, HG. JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders.. Leukemia. March 2006, 20 (3): 471–6. PMID 16408098. S2CID 1907521. doi:10.1038/sj.leu.2404081.
- ^ Takeuchi, S; Sugito, S; Uemura, Y; Miyagi, T; Kubonishi, I; Taguchi, H; Enzan, H; Ohtsuki, Y; Miyoshi, I. Acute megakaryoblastic leukemia: establishment of a new cell line (MKPL-1) in vitro and in vivo.. Leukemia. June 1992, 6 (6): 588–94. PMID 1602796.
- ^ Raskind, WH; Disteche, CM; Keating, A; Singer, JW. Correlation between cytogenetic and molecular findings in human chronic myelogenous leukemia lines EM-2 and EM-3.. Cancer Genetics and Cytogenetics. April 1987, 25 (2): 271–84. PMID 3030532. doi:10.1016/0165-4608(87)90188-9.
- ^
Lozzio CB, Lozzio BB. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood. March 1975, 45 (3): 321–334. PMID 163658. doi:10.1182/blood.V45.3.321.321 .
- ^ Drexler HG. The Leukemia-Lymphoma Cell Line Factsbook. San Diego: Academic Press. 2000.
- ^ Kubonishi, I; Miyoshi, I. Establishment of a Ph1 chromosome-positive cell line from chronic myelogenous leukemia in blast crisis.. International Journal of Cell Cloning. June 1983, 1 (2): 105–17. PMID 6321612. doi:10.1002/stem.5530010205.
- ^ Kishi, K. A new leukemia cell line with Philadelphia chromosome characterized as basophil precursors.. Leukemia Research. 1985, 9 (3): 381–90. PMID 3858609. doi:10.1016/0145-2126(85)90060-8.
- ^ Seigneurin, D; Champelovier, P; Mouchiroud, G; Berthier, R; Leroux, D; Prenant, M; McGregor, J; Starck, J; Morle, F; Micouin, C. Human chronic myeloid leukemic cell line with positive Philadelphia chromosome exhibits megakaryocytic and erythroid characteristics.. Experimental Hematology. September 1987, 15 (8): 822–32. PMID 3476310.
- ^ Pegoraro, L; Matera, L; Ritz, J; Levis, A; Palumbo, A; Biagini, G. Establishment of a Ph1-positive human cell line (BV173).. Journal of the National Cancer Institute. March 1983, 70 (3): 447–53. PMID 6572735.
- ^ Kuriyama, K; Gale, RP; Tomonaga, M; Ikeda, S; Yao, E; Klisak, I; Whelan, K; Yakir, H; Ichimaru, M; Sparkes, RS. CML-T1: a cell line derived from T-lymphocyte acute phase of chronic myelogenous leukemia.. Blood. September 1989, 74 (4): 1381–7. PMID 2788468. S2CID 16883925. doi:10.1182/blood.V74.4.1381.1381 .
- ^ Minowada, J; Tsubota, T; Greaves, MF; Walters, TR. A non-T, non-B human leukemia cell line (NALM-1): establishment of the cell line and presence of leukemia-associated antigens.. Journal of the National Cancer Institute. July 1977, 59 (1): 83–7. PMID 301573. doi:10.1093/jnci/59.1.83.
- ^ Watanabe, T; Kataoka, T; Mizuta, S; Kobayashi, M; Uchida, T; Imai, K; Wada, H; Kinoshita, T; Murate, T; Mizutani, S. Establishment and characterization of a novel cell line, TK-6, derived from T cell blast crisis of chronic myelogenous leukemia, with the secretion of parathyroid hormone-related protein.. Leukemia. November 1995, 9 (11): 1926–34. PMID 7475285.
- ^ Uozumi, K; Otsuka, M; Ohno, N; Moriyama, T; Suzuki, S; Shimotakahara, S; Matsumura, I; Hanada, S; Arima, T. Establishment and characterization of a new human megakaryoblastic cell line (SET-2) that spontaneously matures to megakaryocytes and produces platelet-like particles.. Leukemia. January 2000, 14 (1): 142–52. PMID 10637490. S2CID 3258153. doi:10.1038/sj.leu.2401608.
